WO2012150679A1 - Dialysis device and method for priming dialysis device - Google Patents

Dialysis device and method for priming dialysis device Download PDF

Info

Publication number
WO2012150679A1
WO2012150679A1 PCT/JP2012/060820 JP2012060820W WO2012150679A1 WO 2012150679 A1 WO2012150679 A1 WO 2012150679A1 JP 2012060820 W JP2012060820 W JP 2012060820W WO 2012150679 A1 WO2012150679 A1 WO 2012150679A1
Authority
WO
WIPO (PCT)
Prior art keywords
dialyzer
blood
chamber
dialysate
passage
Prior art date
Application number
PCT/JP2012/060820
Other languages
French (fr)
Japanese (ja)
Inventor
満隆 上田
利春 沢田
隆一郎 美多
Original Assignee
ニプロ株式会社
澁谷工業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニプロ株式会社, 澁谷工業株式会社 filed Critical ニプロ株式会社
Publication of WO2012150679A1 publication Critical patent/WO2012150679A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3643Priming, rinsing before or after use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3643Priming, rinsing before or after use
    • A61M1/3644Mode of operation

Definitions

  • the present invention relates to a dialysis device and a priming method of the dialysis device, and more specifically, the blood circuit and the dialyzer are filled with physiological saline or the like.
  • the present invention relates to a dialysis apparatus and a priming method for the dialysis apparatus.
  • the blood circuit and dialyzer are filled with a priming solution such as physiological saline as the previous step, so that no air remains in the dialyzer and blood circuit.
  • a priming solution such as physiological saline
  • This priming is performed in order to prevent bubbles from entering the patient's body from the blood circuit during dialysis treatment.
  • a first general priming method a method using physiological saline is known, and as a second method, the fluid pressure in the dialysate circuit is more positive than the fluid pressure in the blood circuit.
  • a method is known in which dialysate is introduced into a blood chamber under pressure, so that the dialyzer is filled into the dialyzer and blood circuit by so-called “reverse filtration” (Patent Documents 1 to 3).
  • a conventional general dialyzer includes a number of hollow fiber membranes inside a cylindrical outer case, and the internal space of these hollow fiber membranes and the hollow fiber membranes. Adjacent regions at both ends are blood chambers.
  • the blood chamber communicates with the artery side passage of the blood passage through the first port which is one end of the exterior case, and communicates with the vein side passage of the blood passage from the second port which is the other end of the exterior case.
  • the blood chamber and the blood circuit (arterial side passage, venous side passage) communicating with the blood chamber are filled with the priming solution.
  • small bubbles in the hollow fiber membrane of the dialyzer It tends to accumulate in the adjacent region (first port) at the end of the hollow fiber membrane on the side (see FIG. 6).
  • the physiological saline solution as the priming solution has poor fluidity, it is difficult to reliably remove bubbles remaining in the upper part of the blood chamber in the outer case by the conventional priming method.
  • the first present invention includes a dialyzer having a blood chamber and a dialysate chamber therein, an artery having one end serving as a blood collection port, and the other end connected to one end of the blood chamber of the dialyzer.
  • a blood circuit having a side passage and one end serving as a blood return port, and the other end connected to the other end of the blood chamber, and a dialysate supply passage connected to the inlet of the dialysate chamber in the dialyzer
  • a dialysis fluid circuit having a dialysis fluid recovery passage connected to the outlet of the dialysis chamber, and a priming fluid supply means for supplying a priming fluid to the blood chamber of the dialyzer and the blood circuit
  • Gas introduction means for introducing gas into the blood circuit from a gas introduction port provided in the artery side passage or vein side passage is provided, and the gas is supplied to the blood chamber of the dialyzer and the blood circuit filled with the priming liquid.
  • the second aspect of the present invention also includes a dialyzer having a blood chamber and a dialysate chamber therein, an arterial passage and one end connected to one end of the blood chamber of the dialyzer with one end serving as a blood collection port.
  • a blood circuit having a vein-side passage connected to the other end of the blood chamber, the dialysate supply passage connected to the inlet of the dialysate chamber in the dialyzer, and the dialysis chamber
  • a dialysate circuit having a dialysate recovery passage connected to an outlet of the dialyzer, and a priming fluid supply means for supplying a priming fluid to the blood chamber of the dialyzer and the blood circuit, and the blood chamber and blood of the dialyzer
  • a first priming step for filling the blood chamber of the dialyzer and the blood circuit with a priming solution; a gas introduction step for replacing a predetermined region of the blood chamber of the dialyzer filled with the priming solution with a gas; and the gas introduction step.
  • a second priming step of refilling a predetermined region of the blood chamber replaced with gas with a priming solution.
  • the gas introduced into the blood chamber and the bubbles are integrated, and the integrated gas replaces the priming liquid, and then the priming is performed.
  • the gas in the blood chamber is discharged outside the dialyzer and the blood circuit. Therefore, the gas in the blood chamber and blood circuit of the dialyzer can be reliably removed. Therefore, air bubbles can be reliably removed from the blood chamber and blood circuit of the dialyzer without imposing a work burden on the medical staff.
  • FIGS. 3A and 3B are process diagrams when priming is performed using a physiological saline by the dialysis apparatus shown in FIG. 1, FIG. 3A shows the first stage, FIG. 3B shows the second stage, and FIG. ) Shows the third stage.
  • FIG. 4 is a process diagram when priming is performed by reverse filtration using the dialyzer shown in FIG. 1, FIG. 4 (a) shows the first stage, FIG. 4 (b) shows the second stage, and FIG. Three stages are shown.
  • the circuit diagram which shows the principal part of the other Example of this invention.
  • the dialysis apparatus 1 is powered by a power source such as a hospital outlet C and is provided in a box-shaped main body 1A.
  • the operation is controlled by the control means 1B.
  • a dialyzer 1 according to the present embodiment is connected to a dialyzer 2 having a columnar shape, which is held in a vertical direction on the side surface of the main body 1A, a blood circuit 3 connected to the dialyzer 2, and the dialyzer 2.
  • a dialysate circuit 4 provided in the main body 1A.
  • the control means 1B is provided with a screen display type operation panel 1C, and buttons, icons, and messages necessary for the operation are displayed on the screen so that operation of the apparatus and setting of various parameters can be performed. .
  • the dialysis apparatus 1 of the present embodiment is a dialysis apparatus that performs hemodialysis therapy (HD) on one patient, and performs priming before the use of the dialysis apparatus 1 is started.
  • the dialysis apparatus 1 allows the patient to supplement the dialysate via the dialyzer 2 and the blood circuit 3 by making the dialysate circuit 4 side more positive than the blood circuit 3 side during dialysis treatment. It has become.
  • the replacement of the dialysate with the patient through the dialyzer 2 and the blood circuit 3 with the dialysate circuit 4 side at a positive pressure is generally called “reverse filtration”.
  • the dialyzer 2 in priming to fill the blood circuit 3 and the dialyzer 2 with a liquid in the stage before the dialysis treatment, the dialyzer 2 is subjected to “reverse filtration” by the dialyzer 1.
  • the priming can be performed by filling the inside of the blood circuit 3 and the blood circuit 3 with the dialysate, and the priming can be performed by filling the blood circuit 3 and the dialyzer 2 with the dialysate. That is, the dialysis apparatus 1 of the present embodiment can perform priming by two types of methods, the method using the physiological saline and the method using “reverse filtration”.
  • the dialyzer 2 includes an outer case 2A made of a cylindrical resin and a number of hollow fiber membranes 2B provided in a bundle inside the outer case 2A. And the inside of each said hollow fiber membrane 2B becomes a filtration membrane (semipermeable membrane), and the adjacent area
  • the hollow fiber membrane 2B as the filtration membrane has a property of allowing liquid to pass but not allowing gas to pass.
  • the adjacent region at one end in the longitudinal direction of the hollow fiber membrane 2B is the first port 2G of the outer case 2A, and the adjacent region at the other end in the longitudinal direction is the second port 2H of the outer case 2A.
  • the internal space of both ports 2G and 2H also constitutes the blood chamber 2C, and one of the ports 2G and 2H is one end in the longitudinal direction of the blood chamber 2C, and the other is in the longitudinal direction of the blood chamber 2C. The other end.
  • one end of the artery side passage 11 is connected to the first port 2G
  • one end of the vein side passage 12 is connected to the second port 2H.
  • the dialyzer 2 is held vertically by the main body 1A so that the first port 2G is upward and the second port 2H is downward. ing.
  • the blood chamber 2C of the dialyzer 2 communicates with the blood circuit 3 so that blood flows through the blood chamber 2C.
  • the space between the inner peripheral surface of the cylindrical outer case 2A and the blood chamber 2C (each hollow fiber membrane 2B) is a dialysate chamber 2D through which dialysate flows.
  • An inlet 2E for introducing dialysate into the dialysate chamber 2D is formed at the lower part of the outer peripheral surface of the outer case 2A, and an outlet 2F for discharging dialysate at the upper part of the outer peripheral surface of the outer case 2A. Is formed.
  • the dialysate supply passage 23 of the dialysate circuit 4 is connected to the inlet 2E, and the dialysate recovery passage 24 of the dialysate circuit 4 is connected to the outlet 2F.
  • the dialysate chamber 2D communicates with the dialysate circuit 4 so that the dialysate flows in the opposite direction to the blood.
  • the dialyzer 2 is held vertically on the side surface of the main body 1A so that the inlet 2E is downward and the outlet 2F is upward during dialysis treatment.
  • the blood circuit 3 is connected to a patient to circulate blood in the blood chamber 2C of the dialyzer 2 and the dialysate from the dialysate circuit 4 to the dialysate chamber 2D of the dialyzer 2. Dialysis treatment is performed on patients.
  • the blood circuit 3 connected to the dialyzer 2 includes an arterial side passage 11 connected to a blood vessel of the patient and supplying blood to the blood chamber 2C of the dialyzer 2, and a venous side passage 12 for returning blood from the blood chamber 2C of the dialyzer 2 to the patient.
  • These passages are formed of resin tubes.
  • One end of the artery side passage 11 is connected to the first port 2G of the dialyzer 2, and the other end of the artery side passage 11 is provided with a puncture needle 11a for puncturing a patient's blood vessel.
  • a clamp means 13 for closing the artery side passage 11 a blood pump 14 for feeding blood, and a drip chamber 15 are disposed in the artery side passage 11 in order from the puncture needle 11 a side.
  • the blood pump 14 is a roller pump that squeezes the tube and supplies the blood, and the operation is controlled by the control means 1B so that blood can be supplied from the patient to the blood chamber 2C of the dialyzer 2. It has become.
  • the drip chamber 15 of the artery side passage 11 is adjusted in height by the liquid level adjusting means 5 described later.
  • One end of the atmospheric passage 6 is connected to the drip chamber 15, and a pressure gauge 16 is provided in the middle of the atmospheric passage 6.
  • One end of the vein side passage 12 is connected to the second port 2H of the blood chamber 2C of the dialyzer 2, and the other end of the vein side passage 12 is provided with a puncture needle 12a for puncturing a patient's blood vessel.
  • a drip chamber 15 ′ and a clamping means 13 ′ as a closing means for closing the vein side passage 12 are disposed in order from the dialyzer 2.
  • the drip chamber 15 ′ is also adjusted in liquid level by the liquid level adjusting means 5.
  • An atmospheric passage 6 ' is connected to the drip chamber 15', and a pressure gauge 16 'is provided in the atmospheric passage 6'.
  • the other end 6a ′ of the atmospheric passage 6 ′ is connected to the upstream portion of the atmospheric passage 6 and is connected to the atmosphere by the communication passage 7 disposed closer to the dialyzer 2 than the other end 6a ′ of the atmospheric passage 6 ′.
  • the passage 6 'and the atmospheric passage 6 communicate with each other.
  • An open / close valve V101 is disposed in the atmospheric passage 6 ′ closer to the end 6a ′ than the communication passage 7, while an air pump 8 is provided in the atmospheric passage 6 closer to the end 6a ′ than the communication passage 7. ing.
  • an open / close valve V102 is disposed in the atmospheric passage 6 closer to the dialyzer 2 than the communication passage 7, and an open / close valve V103 is provided in the atmospheric passage 6 ′ closer to the dialyzer 2 than the communication passage 7. ing.
  • the operation of each of the on-off valves V101 to V103 and the air pump 8 is controlled by the control means 1B.
  • the pressure in each drip chamber 15 and 15 'measured by the pressure gauges 16 and 16' is transmitted to the control means 1B.
  • An aseptic filter 9 for purifying the atmosphere is disposed at the other end of the atmospheric passage 6 serving as an air inlet, and the air purified by the aseptic filter 9 is drip through the atmospheric passages 6 and 6 '.
  • the liquid level adjusting means 5 is constituted by the atmospheric passages 6 and 6 ′, the on-off valves V 101 to V 103 and the air pump 8.
  • the liquid level adjusting means 5 adjusts the height of the liquid level in both the drip chambers 15 and 15 '.
  • the drip chamber 15 on the artery side has a substantially cylindrical shape which is sealed, and the upstream end of the artery side passage 11 between the dialyzer 2 and the bottom 15A is connected. Yes.
  • the downstream end of the artery side passage 11 on the blood pump 14 side is connected, and one end of the atmospheric passage 6 of the liquid level preparation means 5 is connected.
  • the configuration of the drip chamber 15 ′ on the vein side shown in FIG. 3 is the same as the configuration of the drip chamber 15 shown in FIG.
  • the upstream end of the venous passage 12 on the clamping means 13 'side is connected to the bottom 15A' of the drip chamber 15 ', and the downstream end of the venous passage 12 on the dialyzer 2 side is connected to the ceiling 15B'. While being connected, the end of the air passage 6 ′ of the liquid level adjusting means 5 is connected.
  • the amount of gas occupying the upper space in the drip chambers 15 and 15 ′ is increased or decreased by the liquid level adjusting means 5.
  • the liquid level in the drip chamber 15 can be adjusted to a required height (see FIGS. 3A and 4A).
  • the liquid level adjusting means 5 is also used for priming to fill the blood circuit 3 and the blood chamber 2C of the dialyzer 2 with dialysate before dialysis treatment.
  • the drip chamber 15 is used for priming. , 15 'is adjusted. During dialysis treatment, the liquid level in the drip chambers 15 and 15 'is maintained at a required height by the liquid level adjusting means 5.
  • the adjustment of the liquid surface height of the drip chamber 15 on the artery side by the liquid surface preparation means 5 is performed as follows.
  • the control means 1B opens the on-off valve V102 with both the on-off valves V101, V103 closed, and rotates the air pump 8 forward or backward.
  • air is introduced into the drip chamber 15 through the air pump 8 and the on-off valve V102 after the atmosphere is introduced into the atmosphere passage 6.
  • the volume of the upper space in the sealed drip chamber 15 is changed so that the liquid level of the liquid (blood, physiological saline, etc.) in the drip chamber 15 is maintained at a required height. (See FIGS. 2 and 4A).
  • the adjustment of the liquid surface height in the drip chamber 15 'on the vein side by the liquid surface preparation means 5 is performed as follows.
  • the control means 1B opens the on-off valve V103 with both the on-off valves V102 and V101 closed, and rotates the air pump 8 forward or backward.
  • air is introduced into the drip chamber 15 ′ through the air passage 6 before and after the air pump 8, the communication passage 7 and the air passage 6 ′ connected thereto.
  • the volume of the upper space in the sealed drip chamber 15 ′ is changed, so that the liquid level of the liquid (blood, physiological saline, etc.) in the drip chamber 15 ′ is maintained at a required height. (See FIGS. 2 and 3A).
  • the aseptic filter 9 Since the aseptic filter 9 is provided in the atmosphere passage 6, clean air purified by the aseptic filter 9 is introduced into both the drip chambers 15 and 15 '.
  • the liquid level adjusting means 5 is also used as a gas introducing means, and air is introduced into any of the ports 2G and 2H on the upper side in the dialyzer 2 during priming. The air and the small bubbles in the ports 2G and 2H are integrated and then discharged to the outside of the blood chamber 2c.
  • the artery-side passage 11 upstream of the blood pump 14 is connected via the connection tube 18.
  • the raw food bag 17 is connected.
  • a clamping means 19 for closing the connection tube 18 is arranged in the middle of the connection tube 18. If the clamp means 19 is opened after the saline bag 17 is connected to the artery side passage 11 via the connection tube 18, the physiological saline in the saline bag 17 flows down and the artery side passage 11, the blood chamber of the dialyzer 2 2C and the venous passage 12 are introduced.
  • priming is performed by filling the saline solution 17 in the saline bag 17 into the blood circuit 3 and the blood chamber 2 ⁇ / b> C of the dialyzer 2.
  • the dialyzer 2, blood circuit 3 and liquid level adjusting means 5 of the present embodiment are configured as described above.
  • the dialysate circuit 4 includes a dialysate supply passage 23 that supplies fresh dialysate from the first dialysate chamber 21 or the second dialysate chamber 22 to the dialysate chamber 2D of the dialyzer 2, and A dialysate recovery passage 24 for recovering the used dialysate that has passed through the fluid chamber 2D to the first dialysate chamber 21 or the second dialysate chamber 22 is provided, and these passages are constituted by resin tubes. ing.
  • the first and second dialysate chambers 21 and 22 are provided with a supply passage 25 through which fresh dialysate supplied from a dialysate production apparatus (not shown) flows, and drainage for discharging used dialysate.
  • the passage 26 is connected.
  • the first dialysate chamber 21 and the second dialysate chamber 22 have the same configuration, and the inside thereof is partitioned by two diaphragms. That is, between supply chambers 21a and 22a for supplying fresh dialysate, recovery chambers 21b and 22b for recovering used dialysate, and between these supply chambers 21a and 22a and recovery chambers 21b and 22b. It is divided into intermediate chambers 21c and 22c formed in the above.
  • the intermediate chambers 21c and 22c are filled with silicone oil, and the silicone oil in the intermediate chambers 21c and 22c is sent between the intermediate chambers 21c and 22c by the oil pump 27.
  • the volumes of the intermediate chambers 21c and 22c are increased or decreased.
  • the volume of the intermediate chambers 21c and 22c of the chambers 21 and 22 is increased or decreased by the oil pump 27, so that the dialysis solution can be supplemented to the patient by performing reverse filtration during dialysis treatment.
  • priming is performed by reverse filtration before the start of dialysis treatment.
  • the liquid supply passage 25 is provided with a liquid supply pump 31 for supplying the dialysate, and the liquid supply passage 25 is branched in two directions on the downstream side of the liquid supply pump 31 to separate the first and second dialysis.
  • the liquid chambers 21 and 22 are connected to the supply chambers 21a and 22a.
  • the branched passages are respectively provided with liquid supply valves V1 and V2 that are opened and closed by the control means 1B.
  • the dialysate supply passage 23 has an upstream portion branched in two directions and connected to the supply chambers 21a and 22a of the first and second dialysate chambers 21 and 22, respectively.
  • the branch portions are provided with supply valves V3 and V4 which are opened and closed by the control means 1B, respectively.
  • a first dialysate filter F1 and a second dialysate filter F2 for removing harmful components of the dialysate are arranged in series at a predetermined interval in a place near the dialyzer 2 in the dialysate supply passage 23.
  • a first on-off valve V5 that is opened and closed by the control means 1B is provided at a location between the second dialysate filter F2 and the dialyzer 2. Opening means 32 for opening the dialysate supply passage 23 to the atmosphere when necessary is connected to the dialysate supply passage 23 that is located between the two filters F1 and F2.
  • the first dialysate filter F1 is divided into a primary side (upstream chamber) and a secondary side (downstream chamber) by a semipermeable membrane, and dialysate passes through the semipermeable membrane from the primary side (upstream chamber). Thus, harmful components are removed when permeating to the secondary side (downstream chamber).
  • a first bypass passage 33 that connects the dialysate supply passage 23 and the dialysate recovery passage 24 is connected to the primary side (upstream chamber) of the first dialysate filter F1. Is provided with a second on-off valve V6 which is opened and closed by the control means 1B.
  • the second dialysate filter F2 is also divided into a primary side (upstream chamber) and a secondary side (downstream chamber) by a semipermeable membrane, and the dialysate passes through the semipermeable membrane from the primary side (upstream chamber). Harmful components are removed when permeating to the secondary side (downstream chamber).
  • a second bypass passage 34 that connects the dialysate supply passage 23 and the dialysate recovery passage 24 is connected to the primary side (upstream chamber) of the second dialysate filter F2.
  • a third on-off valve V7 that is opened and closed by the control means 1B is provided.
  • the first on-off valve V5 is opened, while the second on-off valve V6 and the third on-off valve V7 are closed.
  • the control means 1B closes the first on-off valve V5 and opens the second on-off valve V6.
  • the dialysate having a poor concentration can be fed to the dialysate recovery passage 24 via the first bypass passage 33 without flowing through the dialyzer 2.
  • both dialysate filters F 1 and F 2 are arranged in series in the dialysate supply passage 23, and both bypass passages 33 and 34 extend across the dialysate supply passage 23 and the dialysate recovery passage 24. Are arranged in parallel.
  • an opening means 32 is provided in order to detect leakage of both the dialysate filters F1, F2.
  • the opening means 32 includes an opening passage 35 connected between the dialysate filters F1 and F2 in the dialysate supply passage 23, and a fourth on-off valve V8 provided in the opening passage 35 and opened and closed by the control means 1B. And a check valve 36 provided in the open passage 35 for preventing the dialysate from flowing out, and a sterile filter 37 for purifying the inflowing air.
  • the opening means 32 is used for checking the leakage of the dialysate filters F1 and F2.
  • the opening means 32 is used to check for leakage before or after dialysis treatment. .
  • the control means 1B closes the first on-off valve V5 and opens the second on-off valve V6, the third on-off valve V7, and the fourth on-off valve V8. Then, the inflow of the atmosphere into the dialysate circuit 4 is allowed through the open passage 35, and the secondary side (or primary side) of the dialysate filters F1 and F2 from the secondary side (or secondary side) to the primary side (or secondary side). The leakage of the dialysate filters F1 and F2 can be inspected based on the presence or absence of inflow of air.
  • the dialysate recovery passage 24 has an upstream end connected to the dialysate chamber 2C (exit 2F) of the dialyzer 2 and a downstream portion bifurcated in two directions so that the first and second dialysate respectively.
  • recovery valves V10 and V11 Connected to the recovery chambers 21b and 22b of the chambers 21 and 22, recovery valves V10 and V11 that are opened and closed by the control means 1B are provided at the branch portions, respectively.
  • a pressure sensor 41 for measuring the pressure in the dialysate circuit 4 a dialysate pump 42 for feeding dialysate, and gas in the dialysate And a deaeration tank 43 for degassing the air.
  • a third bypass passage 44 is disposed between the deaeration tank 43 and the drainage passage 26.
  • the third bypass passage 44 is provided with a fifth on-off valve V12 that is opened and closed by the control means 1B.
  • a sixth on-off valve V13 that is opened and closed by the control means 1B is provided at a location closer to the dialyzer 2 than the connection portion of the first bypass passage 33 in the dialysate recovery passage 24.
  • the sixth on-off valve V13 is opened while the fifth on-off valve V12 is closed.
  • the fifth on-off valve V12 is opened to allow the dialysate to flow through the third bypass passage 44.
  • the drainage passage 26 has its upstream portion branched in two directions and connected to the recovery chambers 21b and 22b of the first and second dialysate chambers 21 and 22, respectively. It is connected to a drainage pipe (not shown) provided in the engine, and drainage valves V14 and V15 that are opened and closed by the control means 1B are provided at the branch portions.
  • priming for filling the blood circuit 3 and the blood chamber 2C of the dialyzer 2 with a priming solution is performed before dialysis treatment for the patient. Is done.
  • two types of priming can be performed: a method using a physiological saline solution in the saline bag 17 as a priming method and a method using a dialysate by reverse filtration. Therefore, first, a method using the physiological saline solution in the saline bag 17 as the first embodiment and the subsequent dialysis treatment will be described, and then priming by reverse filtration as the second embodiment will be described.
  • the dialyzer 2 is held upside down in the main body 1A upside down from the case of dialysis treatment.
  • maintained at the perpendicular direction the 2nd port 2H becomes an upper end, and the 1st port 2G becomes a lower end (refer Fig.3 (a)).
  • the reason why the dialyzer 2 is held upside down from that during dialysis treatment is that the blood pump 14 is disposed in the artery-side passage 11, so that bubbles are removed when removing bubbles in the liquid. This is to prevent it from stopping in the blood pump 14 and coming out of the outside.
  • the dialyzer 2 is held in the main body 1A so that the first port 2G and one end of the arterial passage 11 connected to the first port 2G become the lower end. Thereafter, as shown in FIG. 2, a medical worker at the site connects the end of the connection tube 18 continuing from the saline bag 17 to the artery side passage 11.
  • the control means 1B opens the clamping means 19 of the connection tube 18 and the blood pump 14 is rotated forward.
  • the physiological saline solution in the saline bag 17 flows down and is sent toward the dialyzer 2 by the blood pump 14. Therefore, a physiological saline solution as a priming solution is introduced into the venous passage 12 through the first port 2G of the dialysis chamber 2C and the blood chamber 2C of the dialyzer 2 from the connection location with the connection tube 18 of the artery side passage 11.
  • the control unit 1B reverses the blood pump 14 at an appropriate timing, the physiological saline is introduced from the connection portion with the connection tube 18 in the artery side passage 11 to the puncture needle 11a.
  • the physiological saline flowing down into the artery side passage 11 is discharged from the puncture needle 11a and passes through the dialyzer 2 and the vein side passage 12.
  • the saline solution is discharged from the puncture needle 12a.
  • the priming proceeds by filling the saline solution 17 of the saline bag 17 into the blood circuit 3 and the blood chamber 2C of the dialyzer 2.
  • the final priming is performed.
  • air is sent from the liquid level adjusting means 5 into the second port 2H via the drip chamber 15 'of the venous passage 12.
  • the control means 1B opens the on-off valve V103 and rotates the air pump 8 in the normal direction with the on-off valves V101, V102 of the liquid level adjusting means 5 closed.
  • control means 1B reverses the blood pump 14 and closes the venous passage 12 by the clamping means 13 ′ (see FIGS. 2, 3A, and 3B).
  • air is supplied to the upper space in the drip chamber 15 ′ via the atmospheric passage 6 ′, and the air in the upper space passes through the vein-side passage 12 and the second port 2 H of the dialyzer 2 and the hollow fiber membrane 2 B. It is supplied to the upper part (see FIG. 3B).
  • the small bubbles in the second port 2H are integrated with the newly introduced air via the drip chamber 15 ′ and the vein passage 12, and the upper end of the blood chamber 2C is integrated by the integrated air.
  • a priming solution (physiological saline) is introduced into the blood chamber 2C of the dialyzer 2 from below, while air introduction by the liquid level adjusting means 5 is performed upward into the blood chamber 2C of the dialyzer 2. It is designed to be introduced downward from. That is, the introduction direction of the priming liquid into the blood chamber 2C is opposite to the introduction direction of air.
  • the control means 1B rotates the blood pump 14 forward and reverses the air pump 8, so that the air in the upper space of the drip chamber 15 ′ is discharged through the atmospheric passage 6 ′.
  • the air in the upper region of the blood chamber 2C including the second port 2H and the air in the venous passage 12 is removed, and instead, the physiological saline is filled (see FIG. 3C).
  • the air bubbles in the second port 2H are surely removed from the dialyzer 2 and the vein passage 12.
  • priming is performed twice before and after the air is introduced into the dialyzer 2 by the liquid level adjusting means 5.
  • the operation of the blood pump 14 and the air pump 8 is stopped by the control means 1B, and the closed state of the vein side passage 12 by the clamping means 13 ′ is opened. In this way, the priming using the physiological saline solution of the raw food bag 17 is completed.
  • the following method can also be employed. That is, with the air pump 8 stopped and the on-off valve V102 closed, the control means 1B opens the on-off valves V101, V103 and reverses the blood pump 14. In this case, when the blood pump 14 is reversed, the atmosphere is introduced into the drip chamber 15 ′ and the blood circuit 3 from the atmosphere passage 6 ′ via the on-off valves V 101 and V 103.
  • the dialyzer 2 is inverted to the holding state opposite to that at the time of the priming by the medical staff at the site. That is, as shown in FIG. 1, the first port 2G is located at the upper side and the artery side passage 11 is connected thereto, and the second port 2H is located at the lower side and the venous passage 12 is connected thereto. It becomes a state. Thereafter, dialysis treatment is performed on the patient as in the conventional case. That is, first, before starting dialysis treatment, both puncture needles 11a and 12a are inserted into the patient to connect the blood circuit 3, and then the blood pump 14 is operated to circulate blood through the blood circuit 3.
  • the control means 1B opens the liquid supply valve V1 and the drainage valve V14 and closes the supply valve V3 and the recovery valve V10. Further, the control means 1B operates the liquid supply pump 31 and The first on-off valve V5 and the sixth on-off valve V13 are opened. The other on-off valves V6 to V9 and V12 are closed. Then, in the first dialysate chamber 21, the supply valve V1 and the drain valve V14 are open, so that the dialysate flows into the supply chamber 21a from the supply passage 25 and the diaphragm is in the recovery chamber 21b. The used dialysate that has been pressed and previously filled is discharged to the outside through the drainage passage 26.
  • the control means 1B opens the supply valve V4 and the recovery valve V11, and closes the supply valve V2 and the drain valve V15. Then, the used dialysate sent by the dialysate pump 42 flows into the recovery chamber 22b, so that fresh dialysate is supplied from the supply chamber 22a via the dialysate supply passage 23 to the dialysate 2 in the dialyzer 2. It will be supplied to the chamber 2D.
  • control means 1B alternately opens and closes the liquid supply valves V1 and V2, the supply valves V3 and V4, the recovery valves V10 and V11, and the drain valves V14 and V15, so that the first dialysate chamber 21 and the second dial 2
  • the fresh dialysate is supplied to the dialysate chamber 2D of the dialyzer 2 through the dialysate supply passage 23 through the dialysate chamber 22, while the used dialysate that has passed through the dialysate chamber 2D of the dialyzer 2 is supplied.
  • the liquid is alternately collected in the first dialysate chamber 21 and the second dialysate chamber 22 and discharged to the outside of the dialysate circuit 4 through the drainage passage 26.
  • the dialysate flows from the dialysate circuit 4 to the dialysate chamber 2D of the dialyzer 2, and the blood flows to the blood chamber 2C of the dialyzer 2 via the blood circuit 3, thereby preventing the patient.
  • Dialysis treatment is given.
  • the following processing is performed. That is, the required amount of silicone oil is supplied by the oil pump 27 to the intermediate chamber 21c of the first dialysate chamber 21 where the treated dialysate is collected.
  • the volume of the recovery chamber 21b becomes smaller than the volume of the supply chamber 21a of the first chamber 21, and as a result, the dialysate corresponding to the volume difference flows to the blood circuit 3 via the blood chamber 2C of the dialyzer 2. That is, it is pressed into the patient's blood. In this manner, the dialysate replacement solution is processed by reverse filtration when necessary during dialysis treatment.
  • priming using the physiological saline solution in the saline bag 17 is performed, and then dialysis treatment is performed on the patient.
  • the priming of the second system by reverse filtration which is the second embodiment is performed as follows. That is, in this case, as shown in FIGS. 1 and 4, priming is performed in a state where the dialyzer 2 is held in the vertical direction so that the first port 2G is on the upper side, as in dialysis treatment. That is, the artery side passage 11 is connected to the first port 2G on the upper side, and the vein side passage 12 is connected to the second port 2H on the lower side.
  • a dialysate recovery passage 24 is connected to the outlet 2F on the upper side, and a dialysate supply passage 23 is connected to the inlet 2E on the lower side (see FIG. 4A).
  • the control means 1B reverses the blood pump 14 so that the flow rate is about half of the flow rate by reverse filtration. Therefore, the dialysate is supplied from the dialysate supply passage 23 into the dialysate chamber 2C of the dialyzer 2, and the dialysate is press-fitted into the blood chamber 2C.
  • the dialysate press-fitted into the blood chamber 2C is distributed into the passages 11 and 12 via the ports 2G and 2H by the reverse rotation of the blood pump 14.
  • both the passages 11 and 12 are filled with the dialysate, and the dialysate is also introduced into the drip chamber 15 via the artery side passage 11.
  • the saline bag 17 storing physiological saline is not used.
  • the control means 1B once stops the reverse filtration, and in this state, the blood pump 14 is stopped and the second clamp means 13 ′ is opened. At the same time, the control means 1B opens the on-off valve V102 with the on-off valves V101, V103 closed, and rotates the air pump 8 in the normal direction. As a result, air is introduced into the drip chamber 15 via the atmospheric passage 6, so that the dialysate in the drip chamber 15 is pushed back into the blood chamber 2 ⁇ / b> C of the dialyzer 2 via the artery-side passage 11. . Along with this, the dialysate in the blood chamber 2 ⁇ / b> C is discharged to the vein side passage 12.
  • the air introduced into the drip chamber 15 is introduced into the upper part of the blood chamber 2C including the first port 2G via the artery-side passage 11, the newly introduced air and the first air are introduced first.
  • the air bubbles in the first port 2G are integrated (see FIGS. 4A and 4B). That is, the dialysate in the upper part of the first port 2G and the blood chamber 2C is replaced with air.
  • the introduction direction of the priming liquid into the blood chamber 2C is opposite to the introduction direction of air.
  • the control means 1B closes the second clamping means 13 ′ and then performs reverse filtration again with the dialysate circuit 4 (see FIG. 4C). That is, priming by reverse filtration is performed again.
  • the dialysate is introduced into the blood chamber 2 ⁇ / b> C, and further dialysate is introduced from the first port 2 ⁇ / b> G into the passage 11 and into the drip chamber 15.
  • the air in the upper portion of the first port 2G and the blood chamber 2C on the upper side is discharged to the upper space of the drip chamber 15 via the artery side passage 11. That is, the air bubbles previously in the first port 2G are reliably discharged into the drip chamber 15 together with the air introduced by the liquid level adjusting means 5.
  • the control means 1B reverses the air pump 8
  • the air in the drip chamber 15 is discharged through the atmospheric passage 6, and accordingly, the level of the dialysate in the drip chamber 15 rises to a required height. (See FIG. 4C).
  • the dialysate chamber 2D, blood chamber 2C and blood circuit 3 of the dialyzer 2 are filled with the dialysate as the priming solution by reverse filtration, and the priming is completed.
  • the priming is performed twice before and after the air is introduced into the blood chamber 2C of the dialyzer 2 by the liquid level adjusting means 5.
  • the dialyzer 2 In the case of the priming by reverse filtration, the dialyzer 2 is in the same holding state as that at the time of dialysis treatment, and thereafter, the dialysis treatment can be immediately performed. Thereafter, dialysis treatment by the dialysis apparatus 1 is performed as described above.
  • the ports 2H and 2G of the dialyzer 2 even if small bubbles remain in the ports 2H and 2G of the dialyzer 2 at the time of priming, they are located on the upper side in the final stage of priming.
  • the introduced air and the bubbles in the ports 2H and 2G are integrated.
  • the priming solution in the upper part of the blood chamber 2C located on the upper side is intentionally replaced with a required amount of air.
  • the ports 2H and 2G and the blood chamber 2C are again filled with the priming solution and the air is discharged to the outside of the blood chamber 2C, so that the air bubbles in the blood chamber 2C including the ports 2H and 2G are removed.
  • priming by reverse filtration is performed as the second priming method.
  • reverse filtration may be performed by a different method. That is, for example, as described in Japanese Patent Application Laid-Open No. 2003-180823, the present invention can be applied to remove bubbles by reversely rotating a dewatering pump provided in a dialysate recovery circuit and performing reverse filtration. Can be done. Further, the bubble removal according to the present invention can be performed even by priming by other methods.
  • the liquid level adjusting means 5 is used as the gas introducing means, but the following configuration may be employed instead. That is, as shown in FIG.
  • one gas introduction means 51 is provided in the artery side passage 11 between the drip chamber 15 on the artery side and the dialyzer 2, and the drip chamber 15 ′ on the vein side is dialyzed. What is necessary is just to provide the other gas introduction means 52 in the vein side channel
  • the gas introducing means 51 includes an atmosphere opening passage 53, an opening / closing valve V 105 provided in the atmosphere opening passage 53, an air pump 55, and a sterile filter 56.
  • the other gas introducing means 52 is also configured in the same manner as the gas introducing means 51, each constituent member corresponding to the gas introducing means 51 is indicated by “′”.
  • the gas introduction means 51 and 52 are above the dialyzer 2 held so that the longitudinal direction is the vertical direction. Air is introduced into the blood chamber 2C including each port 2G or 2H to replace the priming solution. After that, by filling the blood chamber 2C including the ports 2G or 2H of the dialyzer 2 again with the priming liquid, the air bubbles in the blood chamber 2C can be reliably removed.

Abstract

A dialysis device is primed by first holding a dialyzer (2) upside down, contrary to the case of dialysis therapy, and then rotating a blood pump (14) to thereby fill up a blood circuit (3) and the inside of the dialyzer (2) with physiological saline contained in a physiological saline bag (17). By a liquid level-adjusting means (5), air is then supplied, through an atmosphere pathway (6'), a drip chamber (15') of a vein side pathway (12) and the vein side pathway (12), into the upper part of a blood chamber (2C) including a second port (2H) [Fig. 3(b)]. Thus, small air bubbles in the second port (2H) of the dialyzer (2) are combined with the air having been supplied through the drip chamber (15). Next, the air is discharged to the outside of the dialyzer (2) by the physiological saline that is supplied again into the blood chamber (2C). Thus, air bubbles in the blood chamber (2C) of the dialyzer (2) can be surely removed in the priming process.

Description

透析装置と透析装置のプライミング方法Dialysis machine and priming method of dialyzer
 本発明は透析装置と透析装置のプライミング方法に関し、より詳しくは、血液回路と透析器内を生理食塩液等で満たす、いわゆる「プライミング」の際に血液回路および透析器内の気泡を確実に除去できるようにした透析装置と透析装置のプライミング方法に関する。 The present invention relates to a dialysis device and a priming method of the dialysis device, and more specifically, the blood circuit and the dialyzer are filled with physiological saline or the like. The present invention relates to a dialysis apparatus and a priming method for the dialysis apparatus.
 従来、透析装置を用いた透析治療においては、その前段階として血液回路と透析器内を生理食塩液等のプライミング液で満たすことで、透析器と血液回路内に空気が残留しないようにしており、この処理は「プライミング」と称されている。このプライミングは、透析治療の際に患者の体内に血液回路から気泡が入るのを防止するために行なわれている。
 そして、従来一般的なプライミングの第1の方法としては生理食塩液を用いる方法が知られており、第2の方法としては、血液回路内の液圧よりも透析液回路内の液圧を陽圧にして透析液を血液室に導入する、いわゆる「逆ろ過」によって透析液を透析器および血液回路内に充満させる方法が知られている(特許文献1~特許文献3)。
Conventionally, in dialysis treatment using a dialysis machine, the blood circuit and dialyzer are filled with a priming solution such as physiological saline as the previous step, so that no air remains in the dialyzer and blood circuit. This process is called “priming”. This priming is performed in order to prevent bubbles from entering the patient's body from the blood circuit during dialysis treatment.
As a first general priming method, a method using physiological saline is known, and as a second method, the fluid pressure in the dialysate circuit is more positive than the fluid pressure in the blood circuit. A method is known in which dialysate is introduced into a blood chamber under pressure, so that the dialyzer is filled into the dialyzer and blood circuit by so-called “reverse filtration” (Patent Documents 1 to 3).
特開平11-33111号公報Japanese Patent Laid-Open No. 11-33111 特開2001-245970号公報JP 2001-245970 A 特開2007-167108号公報JP 2007-167108 A
 ところで、上述した従来のプライミング方法においても、プライミングの際に透析器内に小さな気泡が付着して残留する場合があり、その場合には医療従事者が透析器を叩いて衝撃を与えたり、あるいは、上記特許文献1にあるように、血液ポンプの脈動を用いてプライミング液を送液することで気泡を除去するようにしている。
 しかしながら、従来の前者のやり方は医療従事者に負担を強いることになり、他方、後者のやり方では、透析器内に残留する小さな気泡を確実に除去できない恐れがあった。より詳細には、図6に示すように、従来一般的な透析器は、円筒状の外装ケースの内部に多数の中空糸膜を備えており、これら中空糸膜の内部空間および中空糸膜の両端部の隣接領域が血液室となっている。そして、血液室は、外装ケースの一端となる第1ポートを介して血液通路の動脈側通路に連通するとともに、外装ケースの他端となる第2ポートから血液通路の静脈側通路に連通している。そして、プライミングの際には、血液室とそれに連通する血液回路(動脈側通路、静脈側通路)内がプライミング液で満たされるが、その際、透析器の中空糸膜内の小さな気泡は、上方側となる中空糸膜の端部の隣接領域(第1ポート)内に溜まり易い(図6参照)。しかも、プライミング液としての生理食塩液は流動性が悪いので、上記外装ケース内の血液室の上部に残留した気泡を従来のプライミング方法によって確実に除去するのは困難であった。
By the way, even in the conventional priming method described above, small bubbles may adhere and remain in the dialyzer during priming. In this case, a medical worker strikes the dialyzer to give an impact, or As described in Patent Document 1, air bubbles are removed by feeding a priming solution using the pulsation of a blood pump.
However, the former former method imposes a burden on the medical staff, while the latter method may not reliably remove small bubbles remaining in the dialyzer. More specifically, as shown in FIG. 6, a conventional general dialyzer includes a number of hollow fiber membranes inside a cylindrical outer case, and the internal space of these hollow fiber membranes and the hollow fiber membranes. Adjacent regions at both ends are blood chambers. The blood chamber communicates with the artery side passage of the blood passage through the first port which is one end of the exterior case, and communicates with the vein side passage of the blood passage from the second port which is the other end of the exterior case. Yes. During priming, the blood chamber and the blood circuit (arterial side passage, venous side passage) communicating with the blood chamber are filled with the priming solution. At that time, small bubbles in the hollow fiber membrane of the dialyzer It tends to accumulate in the adjacent region (first port) at the end of the hollow fiber membrane on the side (see FIG. 6). Moreover, since the physiological saline solution as the priming solution has poor fluidity, it is difficult to reliably remove bubbles remaining in the upper part of the blood chamber in the outer case by the conventional priming method.
 上述した事情に鑑み、第1の本発明は、内部に血液室と透析液室とを有する透析器と、一端が採血口となり、他端が上記透析器の血液室の一端に接続される動脈側通路および一端が返血口となり、他端が上記血液室の他端に接続される静脈側通路とを有する血液回路と、上記透析器における透析液室の入口に接続される透析液供給通路および上記透析室の出口に接続される透析液回収通路とを有する透析液回路と、上記透析器の血液室および上記血液回路にプライミング液を供給するプライミング液供給手段とを備える透析装置において、
 上記動脈側通路又は静脈側通路に設けられた気体導入口から血液回路内に気体を導入する気体導入手段を設け、上記プライミング液で満たした上記透析器の血液室および上記血液回路に、上記気体導入口から気体を導入して、上記透析器における血液室の一方の端部とその隣接領域のプライミング液を気体で置換してから該血液室を再びプライミング液で満たすことにより、上記血液回路と上記透析器の血液室から気泡を除去するようにしたものである。
 また、第2の本発明は、内部に血液室と透析液室とを有する透析器と、一端が採血口となり、他端が上記透析器の血液室の一端に接続される動脈側通路および一端が返血口となり、他端が上記血液室の他端に接続される静脈側通路とを有する血液回路と、上記透析器における透析液室の入口に接続される透析液供給通路および上記透析室の出口に接続される透析液回収通路とを有する透析液回路と、上記透析器の血液室および上記血液回路にプライミング液を供給するプライミング液供給手段とを備え、上記透析器の血液室および血液回路にプライミング液を充満させるようにした透析装置のプライミング方法において、
 上記透析器の血液室および上記血液回路をプライミング液で満たす第1プライミング工程と、上記プライミング液で満たされた透析器の血液室の所定領域を気体で置換する気体導入工程と、上記気体導入工程において気体で置換された血液室の所定領域をプライミング液で再度満たす第2プライミング工程とを備えるものである。
In view of the circumstances described above, the first present invention includes a dialyzer having a blood chamber and a dialysate chamber therein, an artery having one end serving as a blood collection port, and the other end connected to one end of the blood chamber of the dialyzer. A blood circuit having a side passage and one end serving as a blood return port, and the other end connected to the other end of the blood chamber, and a dialysate supply passage connected to the inlet of the dialysate chamber in the dialyzer And a dialysis fluid circuit having a dialysis fluid recovery passage connected to the outlet of the dialysis chamber, and a priming fluid supply means for supplying a priming fluid to the blood chamber of the dialyzer and the blood circuit,
Gas introduction means for introducing gas into the blood circuit from a gas introduction port provided in the artery side passage or vein side passage is provided, and the gas is supplied to the blood chamber of the dialyzer and the blood circuit filled with the priming liquid. Introducing the gas from the inlet, replacing one end of the blood chamber in the dialyzer and the priming liquid in the adjacent region with the gas, and then filling the blood chamber again with the priming liquid; Air bubbles are removed from the blood chamber of the dialyzer.
The second aspect of the present invention also includes a dialyzer having a blood chamber and a dialysate chamber therein, an arterial passage and one end connected to one end of the blood chamber of the dialyzer with one end serving as a blood collection port. A blood circuit having a vein-side passage connected to the other end of the blood chamber, the dialysate supply passage connected to the inlet of the dialysate chamber in the dialyzer, and the dialysis chamber A dialysate circuit having a dialysate recovery passage connected to an outlet of the dialyzer, and a priming fluid supply means for supplying a priming fluid to the blood chamber of the dialyzer and the blood circuit, and the blood chamber and blood of the dialyzer In the priming method of the dialysis device in which the circuit is filled with the priming solution,
A first priming step for filling the blood chamber of the dialyzer and the blood circuit with a priming solution; a gas introduction step for replacing a predetermined region of the blood chamber of the dialyzer filled with the priming solution with a gas; and the gas introduction step. And a second priming step of refilling a predetermined region of the blood chamber replaced with gas with a priming solution.
 上述した構成によれば、プライミングの際に血液室内に気泡があったとしても、血液室内に導入される気体と気泡とが一体となり、該一体となった気体によってプライミング液が置換され、それからプライミング液とともに血液室内の気体は透析器および血液回路の外部へ排出される。従って、透析器の血液室および血液回路内の気体を確実に除去することができる。したがって、医療従事者に作業負担を強いることなく、透析器の血液室および血液回路から確実に気泡を除去することができる。 According to the configuration described above, even if there are bubbles in the blood chamber during priming, the gas introduced into the blood chamber and the bubbles are integrated, and the integrated gas replaces the priming liquid, and then the priming is performed. Along with the liquid, the gas in the blood chamber is discharged outside the dialyzer and the blood circuit. Therefore, the gas in the blood chamber and blood circuit of the dialyzer can be reliably removed. Therefore, air bubbles can be reliably removed from the blood chamber and blood circuit of the dialyzer without imposing a work burden on the medical staff.
本発明の一実施例を示す透析装置の斜視図。The perspective view of the dialysis apparatus which shows one Example of this invention. 図1に示した透析装置の回路構成を示す図。The figure which shows the circuit structure of the dialysis apparatus shown in FIG. 図1に示した透析装置により生理食塩液を用いてプライミングを行う際の工程図であり、図3(a)は第1段階、図3(b)は第2段階を示し、図3(c)は第3段階を示している。FIGS. 3A and 3B are process diagrams when priming is performed using a physiological saline by the dialysis apparatus shown in FIG. 1, FIG. 3A shows the first stage, FIG. 3B shows the second stage, and FIG. ) Shows the third stage. 図1に示した透析装置により逆ろ過によってプライミングを行う際の工程図であり、図4(a)は第1段階、図4(b)は第2段階を示し、図4(c)は第3段階を示している。FIG. 4 is a process diagram when priming is performed by reverse filtration using the dialyzer shown in FIG. 1, FIG. 4 (a) shows the first stage, FIG. 4 (b) shows the second stage, and FIG. Three stages are shown. 本発明の他の実施例の要部を示す回路図。The circuit diagram which shows the principal part of the other Example of this invention. 従来一般的な透析器の構成を示す図。The figure which shows the structure of the conventional common dialyzer.
 以下、図示実施例について本発明を説明すると、図1ないし図2において、透析装置1は病院のコンセントCなどの電源から給電されて作動し、また、箱型の本体部1A内に設けられた制御手段1Bによって作動を制御されるようになっている。本実施例の透析装置1は、本体部1Aの側面に鉛直方向に保持される円柱状の透析器2と、この透析器2に接続された血液回路3と、透析器2に接続されるとともに本体部1A内に設けられた透析液回路4とを備えている。
 上記制御手段1Bは画面表示式の操作パネル1Cを備え、その画面には操作に必要なボタンやアイコン、メッセージが表示され、装置の操作および各種パラメータの設定を行うことができるようになっている。
 本実施例の透析装置1は、1人の患者を対象に血液透析療法(HD)を行う透析装置であって、透析装置1の使用開始前にプライミングを行うようになっている。
 また、この透析装置1は、透析治療中において透析液回路4側を血液回路3側よりも陽圧にすることにより、透析器2と血液回路3を介して患者に透析液を補液できるようになっている。このように透析液回路4側を陽圧にして透析器2と血液回路3を介して患者に透析液を補液することは、従来一般的に『逆ろ過』と称されている。そして、本実施例においては、透析治療を実施する前段階において血液回路3と透析器2内を液体で満たすプライミングの際には、透析装置1によって『逆ろ過』を行うことにより、透析器2内と血液回路3内を透析液で満たすことでプライミングを行うことができるとともに、血液回路3と透析器2内に透析液を満たしてプライミングを行うことができるようになっている。つまり、本実施例の透析装置1は、上述した生理食塩液を用いる方法と「逆ろ過」による方法の2種類の方式によりプライミングを行うことができるようになっている。
Hereinafter, the present invention will be described with reference to the illustrated embodiments. In FIGS. 1 and 2, the dialysis apparatus 1 is powered by a power source such as a hospital outlet C and is provided in a box-shaped main body 1A. The operation is controlled by the control means 1B. A dialyzer 1 according to the present embodiment is connected to a dialyzer 2 having a columnar shape, which is held in a vertical direction on the side surface of the main body 1A, a blood circuit 3 connected to the dialyzer 2, and the dialyzer 2. And a dialysate circuit 4 provided in the main body 1A.
The control means 1B is provided with a screen display type operation panel 1C, and buttons, icons, and messages necessary for the operation are displayed on the screen so that operation of the apparatus and setting of various parameters can be performed. .
The dialysis apparatus 1 of the present embodiment is a dialysis apparatus that performs hemodialysis therapy (HD) on one patient, and performs priming before the use of the dialysis apparatus 1 is started.
In addition, the dialysis apparatus 1 allows the patient to supplement the dialysate via the dialyzer 2 and the blood circuit 3 by making the dialysate circuit 4 side more positive than the blood circuit 3 side during dialysis treatment. It has become. Thus, the replacement of the dialysate with the patient through the dialyzer 2 and the blood circuit 3 with the dialysate circuit 4 side at a positive pressure is generally called “reverse filtration”. In the present embodiment, in priming to fill the blood circuit 3 and the dialyzer 2 with a liquid in the stage before the dialysis treatment, the dialyzer 2 is subjected to “reverse filtration” by the dialyzer 1. The priming can be performed by filling the inside of the blood circuit 3 and the blood circuit 3 with the dialysate, and the priming can be performed by filling the blood circuit 3 and the dialyzer 2 with the dialysate. That is, the dialysis apparatus 1 of the present embodiment can perform priming by two types of methods, the method using the physiological saline and the method using “reverse filtration”.
 次に透析器2について説明するが、この透析器2の構成は図6に示した従来公知ものと同じである。すなわち、透析器2は、円筒状の樹脂からなる外装ケース2Aと、該外装ケース2Aの内部に束ねて設けられた多数の中空糸膜2Bとを備えている。そして、上記各中空糸膜2B内がろ過膜(半透膜)となっており、それらの内部および両端部の隣接領域が血液室2Cとなっている。上記ろ過膜としての中空糸膜2Bは、液体は通過させるが気体を通過させない性質を有している。中空糸膜2Bの長手方向の一端の隣接領域は外装ケース2Aの第1ポート2Gとなっており、長手方向の他端の隣接領域は外装ケース2Aの第2ポート2Hとなっている。両ポート2G、2Hの内部空間も上記血液室2Cを構成しており、各ポート2G,2Hのいずれか一方が血液室2Cの長手方向の一端となり、いずれか他方が血液室2Cの長手方向の他端となる。
 図1に示すように、上記第1ポート2Gに動脈側通路11の一端が接続される一方、第2ポート2Hに静脈側通路12の一端が接続されている。この図1に示すように、患者に対する透析治療時には、第1ポート2Gが上方となり、第2ポート2Hが下方となるように、透析器2は本体部1Aに鉛直方向に保持されるようになっている。そして、透析治療時には、透析器2の血液室2Cが上記血液回路3と連通し、血液室2Cを血液が流通するようになっている。
Next, the dialyzer 2 will be described. The configuration of the dialyzer 2 is the same as the conventionally known one shown in FIG. That is, the dialyzer 2 includes an outer case 2A made of a cylindrical resin and a number of hollow fiber membranes 2B provided in a bundle inside the outer case 2A. And the inside of each said hollow fiber membrane 2B becomes a filtration membrane (semipermeable membrane), and the adjacent area | region of those inside and both ends is the blood chamber 2C. The hollow fiber membrane 2B as the filtration membrane has a property of allowing liquid to pass but not allowing gas to pass. The adjacent region at one end in the longitudinal direction of the hollow fiber membrane 2B is the first port 2G of the outer case 2A, and the adjacent region at the other end in the longitudinal direction is the second port 2H of the outer case 2A. The internal space of both ports 2G and 2H also constitutes the blood chamber 2C, and one of the ports 2G and 2H is one end in the longitudinal direction of the blood chamber 2C, and the other is in the longitudinal direction of the blood chamber 2C. The other end.
As shown in FIG. 1, one end of the artery side passage 11 is connected to the first port 2G, while one end of the vein side passage 12 is connected to the second port 2H. As shown in FIG. 1, during dialysis treatment for a patient, the dialyzer 2 is held vertically by the main body 1A so that the first port 2G is upward and the second port 2H is downward. ing. During dialysis treatment, the blood chamber 2C of the dialyzer 2 communicates with the blood circuit 3 so that blood flows through the blood chamber 2C.
 他方、円筒状の外装ケース2Aの内周面と血液室2C(各中空糸膜2B)との間の空間部は透析液が流通する透析液室2Dとなっている。外装ケース2Aの外周面の下部には、透析液室2Dに透析液を導入するための入口2Eが形成されるとともに、外装ケース2Aの外周面の上部には透析液を排出するための出口2Fが形成されている。透析液回路4の透析液供給通路23が入口2Eに接続されるとともに、透析液回路4の透析液回収通路24が出口2Fに接続されている。それにより透析液室2D内は上記透析液回路4と連通して、透析液が血液とは逆方向に流通するようになっている。
 図1に示すように、透析器2は、透析治療時においては、上記入口2Eが下方となり、出口2Fが上方となるように、本体部1Aの側面に鉛直方向に保持されるようになっている。従来公知のように、血液回路3を患者に接続して透析器2の血液室2Cに血液を流通させるとともに透析液回路4からの透析液を透析器2の透析液室2Dに流通させることにより、患者に対して透析治療を行うようになっている。
On the other hand, the space between the inner peripheral surface of the cylindrical outer case 2A and the blood chamber 2C (each hollow fiber membrane 2B) is a dialysate chamber 2D through which dialysate flows. An inlet 2E for introducing dialysate into the dialysate chamber 2D is formed at the lower part of the outer peripheral surface of the outer case 2A, and an outlet 2F for discharging dialysate at the upper part of the outer peripheral surface of the outer case 2A. Is formed. The dialysate supply passage 23 of the dialysate circuit 4 is connected to the inlet 2E, and the dialysate recovery passage 24 of the dialysate circuit 4 is connected to the outlet 2F. As a result, the dialysate chamber 2D communicates with the dialysate circuit 4 so that the dialysate flows in the opposite direction to the blood.
As shown in FIG. 1, the dialyzer 2 is held vertically on the side surface of the main body 1A so that the inlet 2E is downward and the outlet 2F is upward during dialysis treatment. Yes. As conventionally known, the blood circuit 3 is connected to a patient to circulate blood in the blood chamber 2C of the dialyzer 2 and the dialysate from the dialysate circuit 4 to the dialysate chamber 2D of the dialyzer 2. Dialysis treatment is performed on patients.
 次に透析器2に接続された血液回路3について説明する。血液回路3は、患者の血管に接続されて上記透析器2の血液室2Cに血液を供給する動脈側通路11と、透析器2の血液室2Cから患者に血液を戻す静脈側通路12とを備えており、これらの通路は樹脂製のチューブで構成されている。動脈側通路11の一端は上記透析器2の第1ポート2Gに接続されており、動脈側通路11の他端には患者の血管に穿刺される穿刺針11aが設けられている。また、この動脈側通路11には、上記穿刺針11a側から順に、動脈側通路11を閉鎖するクランプ手段13と、血液を送液する血液ポンプ14と、ドリップチャンバ15とが配置されている。上記血液ポンプ14は、チューブをしごいて送液するローラポンプであるとともに、上記制御手段1Bによって作動を制御され、患者から透析器2の血液室2Cへ血液を送液することができるようになっている。 Next, the blood circuit 3 connected to the dialyzer 2 will be described. The blood circuit 3 includes an arterial side passage 11 connected to a blood vessel of the patient and supplying blood to the blood chamber 2C of the dialyzer 2, and a venous side passage 12 for returning blood from the blood chamber 2C of the dialyzer 2 to the patient. These passages are formed of resin tubes. One end of the artery side passage 11 is connected to the first port 2G of the dialyzer 2, and the other end of the artery side passage 11 is provided with a puncture needle 11a for puncturing a patient's blood vessel. In addition, a clamp means 13 for closing the artery side passage 11, a blood pump 14 for feeding blood, and a drip chamber 15 are disposed in the artery side passage 11 in order from the puncture needle 11 a side. The blood pump 14 is a roller pump that squeezes the tube and supplies the blood, and the operation is controlled by the control means 1B so that blood can be supplied from the patient to the blood chamber 2C of the dialyzer 2. It has become.
 上記動脈側通路11のドリップチャンバ15は、後に詳述する液面調整手段5によって内部の液面の高さを調整されるようになっている。このドリップチャンバ15には大気通路6の一端が接続されており、この大気通路6の途中に圧力計16が設けられている。
 上記静脈側通路12の一端は上記透析器2の血液室2Cの第2ポート2Hに接続されており、静脈側通路12の他端には、患者の血管に穿刺される穿刺針12aが設けられている。静脈側通路12には、上記透析器2から順に、ドリップチャンバ15’および静脈側通路12を閉鎖する閉塞手段としてのクランプ手段13’が配置されている。
 ドリップチャンバ15’も液面調整手段5によって液面の高さを調整されるようになっている。ドリップチャンバ15’には、大気通路6’の一端が接続されており、その大気通路6’に圧力計16’が設けられている。大気通路6’の他端6a’は上記大気通路6の上流部分に接続されており、上記大気通路6’の他端6a’よりも透析器2に近い位置に配置された連通路7によって大気通路6’と大気通路6とは相互に連通している。
 連通路7よりも端部6a’側となる大気通路6’には、開閉弁V101が配置される一方、連通路7よりも端部6a’側となる大気通路6にはエアポンプ8が設けられている。また、連通路7よりも透析器2側となる大気通路6には開閉弁V102が配置されており、連通路7よりも透析器2側となる大気通路6’には開閉弁V103が設けられている。各開閉弁V101~V103およびエアポンプ8は、制御手段1Bによって作動を制御されるようになっている。また、圧力計16、16’によって計測された各ドリップチャンバ15、15’内の圧力は制御手段1Bに伝達されるようになっている。
 なお、大気導入口となる大気通路6の他端には、大気を浄化する無菌フィルタ9が配置されており、この無菌フィルター9によって浄化された大気が各大気通路6、6’を介してドリップチャンバ15,15’に導入されるようになっている。本実施例においては、両大気通路6,6’、各開閉弁V101~V103およびエアポンプ8によって液面調整手段5が構成されている。この液面調整手段5によって両ドリップチャンバ15、15’内の液面の高さが調整されるようになっている。
The drip chamber 15 of the artery side passage 11 is adjusted in height by the liquid level adjusting means 5 described later. One end of the atmospheric passage 6 is connected to the drip chamber 15, and a pressure gauge 16 is provided in the middle of the atmospheric passage 6.
One end of the vein side passage 12 is connected to the second port 2H of the blood chamber 2C of the dialyzer 2, and the other end of the vein side passage 12 is provided with a puncture needle 12a for puncturing a patient's blood vessel. ing. In the vein side passage 12, a drip chamber 15 ′ and a clamping means 13 ′ as a closing means for closing the vein side passage 12 are disposed in order from the dialyzer 2.
The drip chamber 15 ′ is also adjusted in liquid level by the liquid level adjusting means 5. One end of an atmospheric passage 6 'is connected to the drip chamber 15', and a pressure gauge 16 'is provided in the atmospheric passage 6'. The other end 6a ′ of the atmospheric passage 6 ′ is connected to the upstream portion of the atmospheric passage 6 and is connected to the atmosphere by the communication passage 7 disposed closer to the dialyzer 2 than the other end 6a ′ of the atmospheric passage 6 ′. The passage 6 'and the atmospheric passage 6 communicate with each other.
An open / close valve V101 is disposed in the atmospheric passage 6 ′ closer to the end 6a ′ than the communication passage 7, while an air pump 8 is provided in the atmospheric passage 6 closer to the end 6a ′ than the communication passage 7. ing. Further, an open / close valve V102 is disposed in the atmospheric passage 6 closer to the dialyzer 2 than the communication passage 7, and an open / close valve V103 is provided in the atmospheric passage 6 ′ closer to the dialyzer 2 than the communication passage 7. ing. The operation of each of the on-off valves V101 to V103 and the air pump 8 is controlled by the control means 1B. Moreover, the pressure in each drip chamber 15 and 15 'measured by the pressure gauges 16 and 16' is transmitted to the control means 1B.
An aseptic filter 9 for purifying the atmosphere is disposed at the other end of the atmospheric passage 6 serving as an air inlet, and the air purified by the aseptic filter 9 is drip through the atmospheric passages 6 and 6 '. It is introduced into the chambers 15 and 15 '. In the present embodiment, the liquid level adjusting means 5 is constituted by the atmospheric passages 6 and 6 ′, the on-off valves V 101 to V 103 and the air pump 8. The liquid level adjusting means 5 adjusts the height of the liquid level in both the drip chambers 15 and 15 '.
 図4(a)に示すように、動脈側のドリップチャンバ15は密閉された略円筒形状となっており、その底部15Aに透析器2との間の動脈側通路11の上流端が接続されている。他方、ドリップチャンバ15の天井15Bには、血液ポンプ14側となる動脈側通路11の下流端が接続されるとともに、上記液面調製手段5の大気通路6の一端が接続されている。
 図3に示した静脈側のドリップチャンバ15’の構成は、上記図4に示したドリップチャンバ15の構成と同じである。そして、このドリップチャンバ15’の底部15A’に静脈側通路12のクランプ手段13’側の上流端が接続されており、天井15B’には透析器2側となる静脈側通路12の下流端が接続されるとともに、液面調整手段5の大気通路6’の端部が接続されている。
 ドリップチャンバ15、15’内に生理食塩液等のプライミング液あるいは血液が貯溜されている状態において、ドリップチャンバ15、15’内の上部空間を占める気体の量を液面調整手段5によって増減させることで、ドリップチャンバ15内の液体の液面高さを所要の高さに調整できるようになっている(図3(a)、図4(a)参照)。
 液面調整手段5は、透析治療前に上記血液回路3と透析器2の血液室2Cに透析液を充満させるプライミングの際にも使用されるようになっており、プライミングの際にドリップチャンバ15、15’の液面の高さを調整するようになっている。また、透析治療中においては、液面調整手段5によってドリップチャンバ15,15’内の血液の液面が所要の高さに維持されるようになっている。
As shown in FIG. 4 (a), the drip chamber 15 on the artery side has a substantially cylindrical shape which is sealed, and the upstream end of the artery side passage 11 between the dialyzer 2 and the bottom 15A is connected. Yes. On the other hand, to the ceiling 15B of the drip chamber 15, the downstream end of the artery side passage 11 on the blood pump 14 side is connected, and one end of the atmospheric passage 6 of the liquid level preparation means 5 is connected.
The configuration of the drip chamber 15 ′ on the vein side shown in FIG. 3 is the same as the configuration of the drip chamber 15 shown in FIG. The upstream end of the venous passage 12 on the clamping means 13 'side is connected to the bottom 15A' of the drip chamber 15 ', and the downstream end of the venous passage 12 on the dialyzer 2 side is connected to the ceiling 15B'. While being connected, the end of the air passage 6 ′ of the liquid level adjusting means 5 is connected.
In the state where priming liquid such as physiological saline or blood is stored in the drip chambers 15 and 15 ′, the amount of gas occupying the upper space in the drip chambers 15 and 15 ′ is increased or decreased by the liquid level adjusting means 5. Thus, the liquid level in the drip chamber 15 can be adjusted to a required height (see FIGS. 3A and 4A).
The liquid level adjusting means 5 is also used for priming to fill the blood circuit 3 and the blood chamber 2C of the dialyzer 2 with dialysate before dialysis treatment. The drip chamber 15 is used for priming. , 15 'is adjusted. During dialysis treatment, the liquid level in the drip chambers 15 and 15 'is maintained at a required height by the liquid level adjusting means 5.
 より詳細には、液面調製手段5による動脈側のドリップチャンバ15の液面高さの調整は次のようにして行われる。制御手段1Bは、両開閉弁V101、V103を閉鎖させた状態で開閉弁V102を開放し、かつエアポンプ8を正転または逆転させる。これにより、大気通路6内に大気が導入されてからエアポンプ8と開閉弁V102を経由してドリップチャンバ15内に空気が導入される。それにより、密閉状態のドリップチャンバ15における上部空間の容積が変更されることで、ドリップチャンバ15内の液体(血液、生理食塩液等)の液面高さが所要の高さに維持されるようになっている(図2、図4(a)参照)。
 他方、液面調製手段5による静脈側のドリップチャンバ15’内の液面高さの調整は次のようにして行われる。制御手段1Bは、開閉弁V102とV101をともに閉鎖させた状態で開閉弁V103を開放させ、かつエアポンプ8を正転または逆転させる。それにより、エアポンプ8の前後の大気通路6、連通路7とそれに接続された大気通路6’を介して空気がドリップチャンバ15’内に導入される。それにより、密閉状態のドリップチャンバ15’における上部空間の容積が変更されることで、ドリップチャンバ15’内の液体(血液、生理食塩液等)の液面高さが所要の高さに維持されるようになっている(図2、図3(a)参照)。なお、大気通路6には無菌フィルタ9が設けられているので、両ドリップチャンバ15,15’内へは、無菌フィルタ9で浄化された清浄な大気が導入される。
 本実施例においては液面調整手段5を気体導入手段として兼用しており、プライミングの際に透析器2内の上方側となるいずれかのポート2G,2H内に空気を導入し、該導入された空気と各ポート2G,2H内の小さな気泡を一体化させてから血液室2cの外部へ排出するようにしている。
More specifically, the adjustment of the liquid surface height of the drip chamber 15 on the artery side by the liquid surface preparation means 5 is performed as follows. The control means 1B opens the on-off valve V102 with both the on-off valves V101, V103 closed, and rotates the air pump 8 forward or backward. As a result, air is introduced into the drip chamber 15 through the air pump 8 and the on-off valve V102 after the atmosphere is introduced into the atmosphere passage 6. Thereby, the volume of the upper space in the sealed drip chamber 15 is changed so that the liquid level of the liquid (blood, physiological saline, etc.) in the drip chamber 15 is maintained at a required height. (See FIGS. 2 and 4A).
On the other hand, the adjustment of the liquid surface height in the drip chamber 15 'on the vein side by the liquid surface preparation means 5 is performed as follows. The control means 1B opens the on-off valve V103 with both the on-off valves V102 and V101 closed, and rotates the air pump 8 forward or backward. As a result, air is introduced into the drip chamber 15 ′ through the air passage 6 before and after the air pump 8, the communication passage 7 and the air passage 6 ′ connected thereto. Thereby, the volume of the upper space in the sealed drip chamber 15 ′ is changed, so that the liquid level of the liquid (blood, physiological saline, etc.) in the drip chamber 15 ′ is maintained at a required height. (See FIGS. 2 and 3A). Since the aseptic filter 9 is provided in the atmosphere passage 6, clean air purified by the aseptic filter 9 is introduced into both the drip chambers 15 and 15 '.
In this embodiment, the liquid level adjusting means 5 is also used as a gas introducing means, and air is introduced into any of the ports 2G and 2H on the upper side in the dialyzer 2 during priming. The air and the small bubbles in the ports 2G and 2H are integrated and then discharged to the outside of the blood chamber 2c.
 図2に示すように、生理食塩液を貯溜した生食バッグ17内の生理食塩液を用いてプライミングを行う場合には、血液ポンプ14よりも上流側の動脈側通路11に接続チューブ18を介して生食バッグ17を接続するようにしている。この場合、接続チューブ18の途中には、該接続チューブ18を閉塞するクランプ手段19が配置される。接続チューブ18を介して生食バッグ17を動脈側通路11に接続してからクランプ手段19を開放させると、生食バッグ17内の生理食塩液が流下して動脈側通路11、透析器2の血液室2C内、および静脈側通路12に導入されるようになっている。このように、生食バッグ17の生理食塩液を血液回路3と透析器2の血液室2C内に充満させることで、プライミングを行なうようになっている。本実施例の透析器2、血液回路3および液面調整手段5は以上のように構成されている。 As shown in FIG. 2, when priming is performed using the physiological saline solution stored in the saline bag 17 in which the physiological saline solution is stored, the artery-side passage 11 upstream of the blood pump 14 is connected via the connection tube 18. The raw food bag 17 is connected. In this case, a clamping means 19 for closing the connection tube 18 is arranged in the middle of the connection tube 18. If the clamp means 19 is opened after the saline bag 17 is connected to the artery side passage 11 via the connection tube 18, the physiological saline in the saline bag 17 flows down and the artery side passage 11, the blood chamber of the dialyzer 2 2C and the venous passage 12 are introduced. In this way, priming is performed by filling the saline solution 17 in the saline bag 17 into the blood circuit 3 and the blood chamber 2 </ b> C of the dialyzer 2. The dialyzer 2, blood circuit 3 and liquid level adjusting means 5 of the present embodiment are configured as described above.
 次に、透析液回路4について説明するが、この透析液回路4の基本構成と作動は例えば特開平10-43290号公報に開示された従来技術と実質的に同じである。すなわち、透析液回路4は、第1透析液チャンバ21または第2透析液チャンバ22から新鮮な透析液を透析器2の透析液室2Dに供給する透析液供給通路23と、透析器2の透析液室2Dを通過した使用済みの透析液を第1透析液チャンバ21または第2透析液チャンバ22に回収する透析液回収通路24とを備えており、これらの通路は樹脂製のチューブで構成されている。
 上記第1、第2透析液チャンバ21、22には、図示しない透析液製造装置から供給される新鮮な透析液の流通する給液通路25と、使用済みの透析液を排出するための排液通路26とが接続されている。
 第1透析液チャンバ21および第2透析液チャンバ22は同じ構成となっており、それらの内部は2枚のダイアフラムによって区画されている。つまり、新鮮な透析液を供給するための供給室21a,22aと、使用済みの透析液を回収するための回収室21b、22bと、これら供給室21a,22aと回収室21b、22bとの間に形成された中間室21c、22cとに区画されている。
Next, the dialysate circuit 4 will be described. The basic configuration and operation of the dialysate circuit 4 are substantially the same as the prior art disclosed in, for example, Japanese Patent Laid-Open No. 10-43290. That is, the dialysate circuit 4 includes a dialysate supply passage 23 that supplies fresh dialysate from the first dialysate chamber 21 or the second dialysate chamber 22 to the dialysate chamber 2D of the dialyzer 2, and A dialysate recovery passage 24 for recovering the used dialysate that has passed through the fluid chamber 2D to the first dialysate chamber 21 or the second dialysate chamber 22 is provided, and these passages are constituted by resin tubes. ing.
The first and second dialysate chambers 21 and 22 are provided with a supply passage 25 through which fresh dialysate supplied from a dialysate production apparatus (not shown) flows, and drainage for discharging used dialysate. The passage 26 is connected.
The first dialysate chamber 21 and the second dialysate chamber 22 have the same configuration, and the inside thereof is partitioned by two diaphragms. That is, between supply chambers 21a and 22a for supplying fresh dialysate, recovery chambers 21b and 22b for recovering used dialysate, and between these supply chambers 21a and 22a and recovery chambers 21b and 22b. It is divided into intermediate chambers 21c and 22c formed in the above.
 上記中間室21c、22cの内部にはそれぞれシリコーンオイルが充満されており、各中間室21c、22c内のシリコーンオイルはオイルポンプ27によって各中間室21cと中間室22cとの間を相互に送液されるようになっており、これにより中間室21c、22cの容積が増減されるようになっている。本実施例においてオイルポンプ27によって各チャンバ21,22の中間室21c、22cの容積を増減させることにより、透析治療中において逆ろ過を行って透析液を患者に補液できるようになっている。また、後述するが、本実施例においては透析治療開始前に逆ろ過によってプライミングを行うようになっている。
 上記給液通路25には上記透析液を送液する給液ポンプ31が設けられるとともに、該給液ポンプ31の下流側において給液通路25は2方向に分岐して上記第1、第2透析液チャンバ21、22の上記供給室21a,22aに接続されている。そして、分岐した通路にはそれぞれ上記制御手段1Bによって開閉される給液弁V1,V2が設けられている。
The intermediate chambers 21c and 22c are filled with silicone oil, and the silicone oil in the intermediate chambers 21c and 22c is sent between the intermediate chambers 21c and 22c by the oil pump 27. As a result, the volumes of the intermediate chambers 21c and 22c are increased or decreased. In the present embodiment, the volume of the intermediate chambers 21c and 22c of the chambers 21 and 22 is increased or decreased by the oil pump 27, so that the dialysis solution can be supplemented to the patient by performing reverse filtration during dialysis treatment. As will be described later, in the present embodiment, priming is performed by reverse filtration before the start of dialysis treatment.
The liquid supply passage 25 is provided with a liquid supply pump 31 for supplying the dialysate, and the liquid supply passage 25 is branched in two directions on the downstream side of the liquid supply pump 31 to separate the first and second dialysis. The liquid chambers 21 and 22 are connected to the supply chambers 21a and 22a. The branched passages are respectively provided with liquid supply valves V1 and V2 that are opened and closed by the control means 1B.
 上記透析液供給通路23は、その上流部分が2方向に分岐してそれぞれ上記第1、第2透析液チャンバ21、22の供給室21a,22aに接続され、下流側の端部は上記透析器2の透析液室2D(入口2E)に接続されている。そして、上記分岐部分にはそれぞれ制御手段1Bによって開閉される供給弁V3,V4が設けられている。
 また、透析液供給通路23における透析器2に近い箇所には、透析液の有害成分を除去する第1透析液フィルターF1および第2透析液フィルターF2が所定間隔を隔てて直列に配置されており、さらに、第2透析液フィルターF2と透析器2との間の箇所には制御手段1Bによって開閉される第1開閉弁V5が設けられている。上記両フィルターF1、F2の間の箇所となる透析液供給通路23には、所要時に透析液供給通路23を大気に開放する開放手段32が接続されている。
The dialysate supply passage 23 has an upstream portion branched in two directions and connected to the supply chambers 21a and 22a of the first and second dialysate chambers 21 and 22, respectively. 2 dialysate chamber 2D (inlet 2E). The branch portions are provided with supply valves V3 and V4 which are opened and closed by the control means 1B, respectively.
Further, a first dialysate filter F1 and a second dialysate filter F2 for removing harmful components of the dialysate are arranged in series at a predetermined interval in a place near the dialyzer 2 in the dialysate supply passage 23. Furthermore, a first on-off valve V5 that is opened and closed by the control means 1B is provided at a location between the second dialysate filter F2 and the dialyzer 2. Opening means 32 for opening the dialysate supply passage 23 to the atmosphere when necessary is connected to the dialysate supply passage 23 that is located between the two filters F1 and F2.
 上記第1透析液フィルターF1内は半透膜によって一次側(上流室)と二次側(下流室)とに区画されており、透析液が一次側(上流室)から半透膜を通過して二次側(下流室)へ透過する際に有害成分が除去されるようになっている。この第1透析液フィルターF1における一次側(上流室)には、上記透析液供給通路23と透析液回収通路24とを連通させる第1バイパス通路33が接続されており、この第1バイパス通路33には上記制御手段1Bによって開閉される第2開閉弁V6が設けられている。
 上記第2透析液フィルターF2内も半透膜によって一次側(上流室)と二次側(下流室)とに区画されており、透析液が一次側(上流室)から半透膜を通過して二次側(下流室)へ透過する際に有害成分が除去される。第2透析液フィルターF2における一次側(上流室)には、透析液供給通路23と透析液回収通路24とを連通させる第2バイパス通路34が接続されており、この第2バイパス通路34には上記制御手段1Bによって開閉される第3開閉弁V7が設けられている。
 患者への透析治療中においては、上記第1開閉弁V5は開放される一方、上記第2開閉弁V6と第3開閉弁V7は閉鎖されるようになっている。これに対して、例えば図示しない濃度センサによって透析液の濃度の不良が検出された場合には、制御手段1Bは上記第1開閉弁V5を閉鎖するとともに第2開閉弁V6を開放する。それにより、濃度不良の透析液を透析器2に流通させることなく第1バイパス通路33を介して透析液回収通路24へと送液できるようになっている。このように、本実施例においては、透析液供給通路23に両透析液フィルターF1、F2が直列に配置されるとともに、透析液供給通路23と透析液回収通路24とにわたって両バイパス通路33,34が並列に配置されている。
The first dialysate filter F1 is divided into a primary side (upstream chamber) and a secondary side (downstream chamber) by a semipermeable membrane, and dialysate passes through the semipermeable membrane from the primary side (upstream chamber). Thus, harmful components are removed when permeating to the secondary side (downstream chamber). A first bypass passage 33 that connects the dialysate supply passage 23 and the dialysate recovery passage 24 is connected to the primary side (upstream chamber) of the first dialysate filter F1. Is provided with a second on-off valve V6 which is opened and closed by the control means 1B.
The second dialysate filter F2 is also divided into a primary side (upstream chamber) and a secondary side (downstream chamber) by a semipermeable membrane, and the dialysate passes through the semipermeable membrane from the primary side (upstream chamber). Harmful components are removed when permeating to the secondary side (downstream chamber). A second bypass passage 34 that connects the dialysate supply passage 23 and the dialysate recovery passage 24 is connected to the primary side (upstream chamber) of the second dialysate filter F2. A third on-off valve V7 that is opened and closed by the control means 1B is provided.
During the dialysis treatment for the patient, the first on-off valve V5 is opened, while the second on-off valve V6 and the third on-off valve V7 are closed. On the other hand, for example, when the concentration sensor (not shown) detects a poor dialysate concentration, the control means 1B closes the first on-off valve V5 and opens the second on-off valve V6. As a result, the dialysate having a poor concentration can be fed to the dialysate recovery passage 24 via the first bypass passage 33 without flowing through the dialyzer 2. Thus, in the present embodiment, both dialysate filters F 1 and F 2 are arranged in series in the dialysate supply passage 23, and both bypass passages 33 and 34 extend across the dialysate supply passage 23 and the dialysate recovery passage 24. Are arranged in parallel.
 そして、本実施例においては、上記両透析液フィルターF1、F2の漏れを検出するために、開放手段32が設けられている。開放手段32は、透析液供給通路23における両透析液フィルターF1、F2の間に接続された開放通路35と、この開放通路35に設けられて制御手段1Bによって開閉される第4開閉弁V8と、開放通路35に設けられて透析液の流出を阻止する逆止弁36と、流入する大気を清浄化する無菌フィルター37とを備えている。
 上記開放手段32は、上記両透析液フィルターF1、F2の漏れの検査に使用されるものであり、透析治療前又は透析治療後の所要時に、この開放手段32を用いて漏れの検査が行われる。より詳細には、所要時に制御手段1Bが上記第1開閉弁V5を閉鎖して第2開閉弁V6、第3開閉弁V7、第4開閉弁V8を開放する。すると、上記開放通路35を介して透析液回路4への大気の流入が許容され、上記両透析液フィルターF1、F2における二次側(又は一次側)から一次側(又は二次側)への大気の流入の有無により、透析液フィルターF1、F2の漏れを検査できるようになっている。
In this embodiment, an opening means 32 is provided in order to detect leakage of both the dialysate filters F1, F2. The opening means 32 includes an opening passage 35 connected between the dialysate filters F1 and F2 in the dialysate supply passage 23, and a fourth on-off valve V8 provided in the opening passage 35 and opened and closed by the control means 1B. And a check valve 36 provided in the open passage 35 for preventing the dialysate from flowing out, and a sterile filter 37 for purifying the inflowing air.
The opening means 32 is used for checking the leakage of the dialysate filters F1 and F2. The opening means 32 is used to check for leakage before or after dialysis treatment. . More specifically, when necessary, the control means 1B closes the first on-off valve V5 and opens the second on-off valve V6, the third on-off valve V7, and the fourth on-off valve V8. Then, the inflow of the atmosphere into the dialysate circuit 4 is allowed through the open passage 35, and the secondary side (or primary side) of the dialysate filters F1 and F2 from the secondary side (or secondary side) to the primary side (or secondary side). The leakage of the dialysate filters F1 and F2 can be inspected based on the presence or absence of inflow of air.
 次に、透析液回収通路24について説明する。透析液回収通路24は、上流側の端部が上記透析器2の透析液室2C(出口2F)に接続されるとともに、下流部分が2方向に分岐してそれぞれ上記第1、第2透析液チャンバ21、22の回収室21b、22bに接続されており、上記分岐部分にはそれぞれ制御手段1Bによって開閉される回収弁V10,V11が設けられている。
 また、透析液回収通路24には、上記透析器2側から順に、透析液回路4内の圧力を測定する圧力センサ41と、透析液を送液する透析液ポンプ42と、透析液内の気体を脱気する脱気槽43とが設けられている。そして、該脱気槽43と排液通路26との間には第3バイパス通路44が配設されている。この第3バイパス通路44には上記制御手段1Bによって開閉される第5開閉弁V12が設けられている。また、透析液回収通路24における第1バイパス通路33の接続部よりも透析器2に近い箇所には、制御手段1Bによって開閉される第6開閉弁V13が設けられている。
 患者に対する透析治療中においては、上記第6開閉弁V13は開放される一方、上記第5開閉弁V12は閉鎖されるようになっている。これに対して、透析器2の漏れを検査する際には第5開閉弁V12が開放されて、上記第3バイパス通路44内に透析液を流通させるようになっている。
 次に、上記排液通路26は、その上流部分が2方向に分岐してそれぞれ上記第1、第2透析液チャンバ21、22の回収室21b、22bに接続され、下流側の端部は医療機関に設備された図示しない排液管に接続されており、さらに、上記分岐部分にはそれぞれ制御手段1Bによって開閉される排液弁V14,V15が設けられている。
Next, the dialysate collection passage 24 will be described. The dialysate recovery passage 24 has an upstream end connected to the dialysate chamber 2C (exit 2F) of the dialyzer 2 and a downstream portion bifurcated in two directions so that the first and second dialysate respectively. Connected to the recovery chambers 21b and 22b of the chambers 21 and 22, recovery valves V10 and V11 that are opened and closed by the control means 1B are provided at the branch portions, respectively.
Further, in the dialysate recovery passage 24, in order from the dialyzer 2 side, a pressure sensor 41 for measuring the pressure in the dialysate circuit 4, a dialysate pump 42 for feeding dialysate, and gas in the dialysate And a deaeration tank 43 for degassing the air. A third bypass passage 44 is disposed between the deaeration tank 43 and the drainage passage 26. The third bypass passage 44 is provided with a fifth on-off valve V12 that is opened and closed by the control means 1B. Further, a sixth on-off valve V13 that is opened and closed by the control means 1B is provided at a location closer to the dialyzer 2 than the connection portion of the first bypass passage 33 in the dialysate recovery passage 24.
During the dialysis treatment for the patient, the sixth on-off valve V13 is opened while the fifth on-off valve V12 is closed. On the other hand, when the leak of the dialyzer 2 is inspected, the fifth on-off valve V12 is opened to allow the dialysate to flow through the third bypass passage 44.
Next, the drainage passage 26 has its upstream portion branched in two directions and connected to the recovery chambers 21b and 22b of the first and second dialysate chambers 21 and 22, respectively. It is connected to a drainage pipe (not shown) provided in the engine, and drainage valves V14 and V15 that are opened and closed by the control means 1B are provided at the branch portions.
 以上の構成からなる透析装置1において、患者に対する透析治療を行う前に、血液回路3および透析器2の血液室2C内をプライミング液で満たすプライミングが行われ、このプライミングが完了してから透析治療が行われる。本実施例においては、プライミングの方式として生食バッグ17内の生理食塩液を用いる方式と、逆ろ過によって透析液を用いる方式との2種類のプライミングを行うことができる。そこで、先ず、第1実施例としての生食バッグ17内の生理食塩液を用いた方式とその後の透析治療について説明し、次に第2実施例としての逆ろ過によるプライミングについて説明する。
 すなわち、生食バッグ17を用いるプライミングの場合には、先ず、透析器2を透析治療時の場合とは上下逆にして本体部1Aに保持させる。これにより、鉛直方向に保持された透析器2は、第2ポート2Hが上端となり、第1ポート2Gが下端となる(図3(a)参照)。なお、このように透析器2を透析治療の際とは上下逆に保持するのは、動脈側通路11には血液ポンプ14が配置されているので、液体内の気泡を除去する際に気泡が血液ポンプ14内に停止して外部へ抜けなくなるのを防止するためである。そのために、本実施例では、第1ポート2Gとそれに接続された動脈通路11の一端が下端となるように、透析器2を本体部1Aに保持させる。
 そして、この後、図2に示すように、現場の医療従事者が生食バッグ17から続く接続チューブ18の端部を動脈側通路11に接続する。
In the dialysis apparatus 1 having the above configuration, priming for filling the blood circuit 3 and the blood chamber 2C of the dialyzer 2 with a priming solution is performed before dialysis treatment for the patient. Is done. In the present embodiment, two types of priming can be performed: a method using a physiological saline solution in the saline bag 17 as a priming method and a method using a dialysate by reverse filtration. Therefore, first, a method using the physiological saline solution in the saline bag 17 as the first embodiment and the subsequent dialysis treatment will be described, and then priming by reverse filtration as the second embodiment will be described.
That is, in the case of priming using the raw food bag 17, first, the dialyzer 2 is held upside down in the main body 1A upside down from the case of dialysis treatment. Thereby, as for the dialyzer 2 hold | maintained at the perpendicular direction, the 2nd port 2H becomes an upper end, and the 1st port 2G becomes a lower end (refer Fig.3 (a)). The reason why the dialyzer 2 is held upside down from that during dialysis treatment is that the blood pump 14 is disposed in the artery-side passage 11, so that bubbles are removed when removing bubbles in the liquid. This is to prevent it from stopping in the blood pump 14 and coming out of the outside. Therefore, in this embodiment, the dialyzer 2 is held in the main body 1A so that the first port 2G and one end of the arterial passage 11 connected to the first port 2G become the lower end.
Thereafter, as shown in FIG. 2, a medical worker at the site connects the end of the connection tube 18 continuing from the saline bag 17 to the artery side passage 11.
 この後、接続チューブ18のクランプ手段19を制御手段1Bが開放させるとともに血液ポンプ14を正転させる。それにより、生食バッグ17内の生理食塩液が流下するとともに血液ポンプ14によって透析器2に向けて送液される。そのため、プライミング液としての生理食塩液は、動脈側通路11の接続チューブ18との接続箇所から透析室2Cの第1ポート2G、透析器2の血液室2Cを通って静脈側通路12に導入される。また、適宜のタイミングで制御手段1Bが血液ポンプ14を逆転させることにより、動脈側通路11における接続チューブ18との接続箇所から穿刺針11aまで生理食塩液が導入される。この時、両クランプ手段13,13’は開放されているので、動脈側通路11内に流下した生理食塩液は穿刺針11aから排出されるとともに、透析器2と静脈側通路12を通過した生理食塩液は穿刺針12aから排出される。このようにして、生食バッグ17の生理食塩液を血液回路3と透析器2の血液室2C内に充満させることで、プライミングが進行する。 Thereafter, the control means 1B opens the clamping means 19 of the connection tube 18 and the blood pump 14 is rotated forward. Thereby, the physiological saline solution in the saline bag 17 flows down and is sent toward the dialyzer 2 by the blood pump 14. Therefore, a physiological saline solution as a priming solution is introduced into the venous passage 12 through the first port 2G of the dialysis chamber 2C and the blood chamber 2C of the dialyzer 2 from the connection location with the connection tube 18 of the artery side passage 11. The In addition, when the control unit 1B reverses the blood pump 14 at an appropriate timing, the physiological saline is introduced from the connection portion with the connection tube 18 in the artery side passage 11 to the puncture needle 11a. At this time, since both the clamp means 13 and 13 'are opened, the physiological saline flowing down into the artery side passage 11 is discharged from the puncture needle 11a and passes through the dialyzer 2 and the vein side passage 12. The saline solution is discharged from the puncture needle 12a. In this way, the priming proceeds by filling the saline solution 17 of the saline bag 17 into the blood circuit 3 and the blood chamber 2C of the dialyzer 2.
 ここで、本実施例では、図3(a)に示すように、プライミング中に上方側に位置する透析器2の第2ポート2H内に小さな気泡が溜まることを考慮して、プライミングの最後の段階において透析器2の血液室2C内の気泡を除去するために、上記液面調整手段5から静脈側通路12のドリップチャンバ15’を介して空気を上記第2ポート2H内に送り込むようにしている。
 すなわち、制御手段1Bは、プライミングの最後の段階で、液面調整手段5の開閉弁V101、V102を閉鎖した状態において、開閉弁V103を開放するとともにエアポンプ8を正転させる。また、これと同時に、制御手段1Bは血液ポンプ14を逆転させるとともに、クランプ手段13’により静脈側通路12を閉鎖する(図2、図3(a)、図3(b)参照)。これにより、大気通路6’を介してドリップチャンバ15’内の上部空間に空気が供給され、該上部空間の空気は静脈側通路12を介して透析器2の第2ポート2Hおよび中空糸膜2B内の上部まで供給される(図3(b)参照)。これにより、第2ポート2H内にあった小さな気泡は、ドリップチャンバ15’と静脈側通路12を経由して新たに導入された空気と一体となり、該一体となった空気によって血液室2Cの上端部となる領域(第2ポート2Hおよび中空糸膜2B)の生理食塩液が置換される(図3(b)参照)。本実施例においては、プライミング液(生理食塩液)を透析器2の血液室2C内に下方側から導入する一方、液面調整手段5による空気の導入は透析器2の血液室2C内へ上方から下方に向けて導入するようになっている。つまり、血液室2Cへのプライミング液の導入方向と空気の導入方向は逆方向になっている。
 この後、制御手段1Bは、血液ポンプ14を正転させるとともに、エアポンプ8を逆転させるので、ドリップチャンバ15’の上部空間の空気が大気通路6’を介して排出される。それに伴って、第2ポート2Hを含めた血液室2Cの上部領域および静脈側通路12内の空気がぬきとられ、それに代わって生理食塩液が充満する(図3(c)参照)。これにより、第2ポート2Hにあった気泡は透析器2と静脈側通路12から確実に除去される。このようにして、本実施例においては、液面調整手段5によって透析器2に空気を導入する前と後とで、2度にわたってプライミングが行われることになる。
 この後、制御手段1Bによって、血液ポンプ14およびエアポンプ8の作動は停止されるとともに、クランプ手段13’による静脈側通路12の閉鎖状態は開放される。このようにして、生食バッグ17の生理食塩液を用いたプライミングが完了する。
 なお、液面調整手段5によるドリップチャンバ15’、血液回路3への空気の導入方式としては、次のような方式も採用することができる。すなわち、エアポンプ8を停止させ、かつ開閉弁V102を閉鎖した状態で、制御手段1Bは開閉弁V101、V103を開放するとともに血液ポンプ14を逆転させる。この場合、血液ポンプ14が逆転されることにより、開閉弁V101,V103を経由して大気通路6’からドリップチャンバ15’と血液回路3に大気が導入される。
Here, in this embodiment, as shown in FIG. 3 (a), in consideration of the accumulation of small bubbles in the second port 2H of the dialyzer 2 located on the upper side during priming, the final priming is performed. In order to remove bubbles in the blood chamber 2C of the dialyzer 2 in the stage, air is sent from the liquid level adjusting means 5 into the second port 2H via the drip chamber 15 'of the venous passage 12. Yes.
That is, in the final stage of priming, the control means 1B opens the on-off valve V103 and rotates the air pump 8 in the normal direction with the on-off valves V101, V102 of the liquid level adjusting means 5 closed. At the same time, the control means 1B reverses the blood pump 14 and closes the venous passage 12 by the clamping means 13 ′ (see FIGS. 2, 3A, and 3B). As a result, air is supplied to the upper space in the drip chamber 15 ′ via the atmospheric passage 6 ′, and the air in the upper space passes through the vein-side passage 12 and the second port 2 H of the dialyzer 2 and the hollow fiber membrane 2 B. It is supplied to the upper part (see FIG. 3B). As a result, the small bubbles in the second port 2H are integrated with the newly introduced air via the drip chamber 15 ′ and the vein passage 12, and the upper end of the blood chamber 2C is integrated by the integrated air. The physiological saline solution in the region (second port 2H and hollow fiber membrane 2B) to be a part is replaced (see FIG. 3B). In this embodiment, a priming solution (physiological saline) is introduced into the blood chamber 2C of the dialyzer 2 from below, while air introduction by the liquid level adjusting means 5 is performed upward into the blood chamber 2C of the dialyzer 2. It is designed to be introduced downward from. That is, the introduction direction of the priming liquid into the blood chamber 2C is opposite to the introduction direction of air.
Thereafter, the control means 1B rotates the blood pump 14 forward and reverses the air pump 8, so that the air in the upper space of the drip chamber 15 ′ is discharged through the atmospheric passage 6 ′. Along with this, the air in the upper region of the blood chamber 2C including the second port 2H and the air in the venous passage 12 is removed, and instead, the physiological saline is filled (see FIG. 3C). Thereby, the air bubbles in the second port 2H are surely removed from the dialyzer 2 and the vein passage 12. Thus, in this embodiment, priming is performed twice before and after the air is introduced into the dialyzer 2 by the liquid level adjusting means 5.
Thereafter, the operation of the blood pump 14 and the air pump 8 is stopped by the control means 1B, and the closed state of the vein side passage 12 by the clamping means 13 ′ is opened. In this way, the priming using the physiological saline solution of the raw food bag 17 is completed.
As a method for introducing air into the drip chamber 15 ′ and the blood circuit 3 by the liquid level adjusting means 5, the following method can also be employed. That is, with the air pump 8 stopped and the on-off valve V102 closed, the control means 1B opens the on-off valves V101, V103 and reverses the blood pump 14. In this case, when the blood pump 14 is reversed, the atmosphere is introduced into the drip chamber 15 ′ and the blood circuit 3 from the atmosphere passage 6 ′ via the on-off valves V 101 and V 103.
 以上のようにして、血液回路3および透析器2内を生理食塩液で満たすプライミングが完了すると、現場の医療従事者によって透析器2が上記プライミングの時とは逆の保持状態に反転させられる。つまり、図1に示すように、第1ポート2Gが上方に位置してそこに動脈側通路11が接続されるとともに、第2ポート2Hが下方に位置してそこに静脈通路12が接続された状態となる。この後は従来と同様に患者に対する透析治療が行われる。すなわち、先ず、透析治療開始前に患者に対して両穿刺針11a、12aを刺して血液回路3を接続し、その後に血液ポンプ14を作動させて血液回路3に血液を流通させる。
 この状態において、上記制御手段1Bは、給液弁V1と排液弁V14を開放するとともに供給弁V3と回収弁V10を閉鎖し、さらに、制御手段1Bは、給液ポンプ31を作動させるとともに第1開閉弁V5、第6開閉弁V13を開放させる。なお、その他の各開閉弁V6~V9、V12は閉鎖されている。すると、第1透析液チャンバ21では、給液弁V1と排液弁V14とが開放されているため、供給室21aには上記給液通路25から透析液が流入し、回収室21bではダイアフラムが押圧されて先に充填されている使用済みの透析液が排液通路26を介して外部へ排出される。
 一方、上記第2透析液チャンバ22では、制御手段1Bが供給弁V4と回収弁V11を開放するとともに給液弁V2と排液弁V15を閉鎖する。すると回収室22bには上記透析液ポンプ42によって送液された使用済みの透析液が流入し、これにより供給室22aから新鮮な透析液が透析液供給通路23を介して透析器2の透析液室2Dに供給されることとなる。
 その後、上記制御手段1Bが上記給液弁V1,V2、供給弁V3,V4、回収弁V10,V11、排液弁V14,V15を交互に開閉することで、第1透析液チャンバ21と第2透析液チャンバ22を介して新鮮な透析液が透析液供給通路23を介して透析器2の透析液室2Dへと供給される一方、透析器2の透析液室2Dを通過した使用済みの透析液は第1透析液チャンバ21と第2透析液チャンバ22に交互に回収されて上記排液通路26を介して透析液回路4の外部へ排出される。
 このように、透析液回路4から透析器2の透析液室2Dへ透析液が流通するとともに、血液回路3を介して透析器2の血液室2Cに血液が流通することで、患者に対して透析治療が施される。
As described above, when the priming for filling the blood circuit 3 and the dialyzer 2 with the physiological saline is completed, the dialyzer 2 is inverted to the holding state opposite to that at the time of the priming by the medical staff at the site. That is, as shown in FIG. 1, the first port 2G is located at the upper side and the artery side passage 11 is connected thereto, and the second port 2H is located at the lower side and the venous passage 12 is connected thereto. It becomes a state. Thereafter, dialysis treatment is performed on the patient as in the conventional case. That is, first, before starting dialysis treatment, both puncture needles 11a and 12a are inserted into the patient to connect the blood circuit 3, and then the blood pump 14 is operated to circulate blood through the blood circuit 3.
In this state, the control means 1B opens the liquid supply valve V1 and the drainage valve V14 and closes the supply valve V3 and the recovery valve V10. Further, the control means 1B operates the liquid supply pump 31 and The first on-off valve V5 and the sixth on-off valve V13 are opened. The other on-off valves V6 to V9 and V12 are closed. Then, in the first dialysate chamber 21, the supply valve V1 and the drain valve V14 are open, so that the dialysate flows into the supply chamber 21a from the supply passage 25 and the diaphragm is in the recovery chamber 21b. The used dialysate that has been pressed and previously filled is discharged to the outside through the drainage passage 26.
On the other hand, in the second dialysate chamber 22, the control means 1B opens the supply valve V4 and the recovery valve V11, and closes the supply valve V2 and the drain valve V15. Then, the used dialysate sent by the dialysate pump 42 flows into the recovery chamber 22b, so that fresh dialysate is supplied from the supply chamber 22a via the dialysate supply passage 23 to the dialysate 2 in the dialyzer 2. It will be supplied to the chamber 2D.
Thereafter, the control means 1B alternately opens and closes the liquid supply valves V1 and V2, the supply valves V3 and V4, the recovery valves V10 and V11, and the drain valves V14 and V15, so that the first dialysate chamber 21 and the second dial 2 The fresh dialysate is supplied to the dialysate chamber 2D of the dialyzer 2 through the dialysate supply passage 23 through the dialysate chamber 22, while the used dialysate that has passed through the dialysate chamber 2D of the dialyzer 2 is supplied. The liquid is alternately collected in the first dialysate chamber 21 and the second dialysate chamber 22 and discharged to the outside of the dialysate circuit 4 through the drainage passage 26.
As described above, the dialysate flows from the dialysate circuit 4 to the dialysate chamber 2D of the dialyzer 2, and the blood flows to the blood chamber 2C of the dialyzer 2 via the blood circuit 3, thereby preventing the patient. Dialysis treatment is given.
 ところで、透析治療中において、患者に対して『逆ろ過』によって透析液を補充する必要が生じた場合には、次のような処理が行われる。つまり、処理済み透析液が回収されている第1透析液チャンバ21の中間室21cに、オイルポンプ27によってシリコーンオイルを所要量供給する。それにより、第1チャンバ21の供給室21aの容量よりも回収室21bの容量が小さくなる結果、それらの容量差に相当する透析液が透析器2の血液室2Cを介して血液回路3へ、すなわち患者の血液へと圧入されることになる。このようにして、透析治療中の所要時に逆ろ過による透析液の補液の処理が行われる。 By the way, during the dialysis treatment, when the patient needs to be replenished with dialysate by “reverse filtration”, the following processing is performed. That is, the required amount of silicone oil is supplied by the oil pump 27 to the intermediate chamber 21c of the first dialysate chamber 21 where the treated dialysate is collected. As a result, the volume of the recovery chamber 21b becomes smaller than the volume of the supply chamber 21a of the first chamber 21, and as a result, the dialysate corresponding to the volume difference flows to the blood circuit 3 via the blood chamber 2C of the dialyzer 2. That is, it is pressed into the patient's blood. In this manner, the dialysate replacement solution is processed by reverse filtration when necessary during dialysis treatment.
 以上のようにして、生食バッグ17内の生理食塩液を用いたプライミングが行われ、その後に患者に対する透析治療が行われる。他方、第2の実施例である逆ろ過による第2の方式のプライミングは次のようにして行われる。
 すなわち、この場合、図1および図4に示すように、透析治療時と同様に、第1ポート2Gが上方側となるように透析器2を鉛直方向に保持した状態でプライミングが行われる。つまり、上方側となる第1ポート2Gには動脈側通路11が接続され、下方側となる第2ポート2Hには静脈側通路12が接続される。また、上方側となる出口2Fには透析液回収通路24が接続され、下方側となる入口2Eには透析液供給通路23が接続される(図4(a)参照)。
 この状態で前述した逆ろ過の処理が行われる。また、この逆ろ過と同時に、制御手段1Bは、逆ろ過による流量の約半分の流量となるように血液ポンプ14を逆転させる。そのため、透析液供給通路23から透析器2の透析液室2C内に透析液が供給され、さらにその透析液は血液室2C内に圧入される。そして、血液室2C内へ圧入された透析液は、上記血液ポンプ14の逆転によって両ポート2G、2Hを経由して両通路11,12内に振り分けられる。それにより、両通路11,12内が透析液で満たされるとともに、動脈側通路11を介してドリップチャンバ15内にも透析液が導入される。なお、この第2実施例においては、生理食塩液を貯溜した生食バッグ17は使用しないようになっている。
 このようにしてプライミングが行われるが、プライミングの最終段階において、透析器2の上方側となる第1ポート2Gに気泡が残っている事を想定して(図4(a)参照)、液面調整手段5を用いて次のようにして気泡の除去処理が行なわれる。
 すなわち、先ず、制御手段1Bは一旦、逆ろ過を停止し、その状態において血液ポンプ14を停止させるとともに、第2クランプ手段13’を開放させる。また、これと同時に制御手段1Bは、開閉弁V101,V103を閉鎖させた状態で開閉弁V102を開放させるとともに、エアポンプ8を正転させる。これにより、大気通路6を介してドリップチャンバ15内に空気が導入されるので、該空気によってドリップチャンバ15内の透析液は動脈側通路11を介して透析器2の血液室2C内に押し戻される。これに伴い、血液室2C内の透析液は静脈側通路12へ排出される。さらに、ドリップチャンバ15内に導入された空気は、動脈側通路11を経由して第1ポート2Gを含めた血液室2Cの上部内まで導入されるので、該新たに導入された空気と先に第1ポート2G内にあった気泡とが一体となる(図4(a)、図4(b)参照)。つまり、第1ポート2Gと血液室2Cの上方部内の透析液が空気と置換されたことになる。なお、この逆ろ過によるプライミングの場合においても、血液室2Cへのプライミング液の導入方向と空気の導入方向は逆方向になっている。
As described above, priming using the physiological saline solution in the saline bag 17 is performed, and then dialysis treatment is performed on the patient. On the other hand, the priming of the second system by reverse filtration which is the second embodiment is performed as follows.
That is, in this case, as shown in FIGS. 1 and 4, priming is performed in a state where the dialyzer 2 is held in the vertical direction so that the first port 2G is on the upper side, as in dialysis treatment. That is, the artery side passage 11 is connected to the first port 2G on the upper side, and the vein side passage 12 is connected to the second port 2H on the lower side. A dialysate recovery passage 24 is connected to the outlet 2F on the upper side, and a dialysate supply passage 23 is connected to the inlet 2E on the lower side (see FIG. 4A).
In this state, the reverse filtration process described above is performed. Simultaneously with the reverse filtration, the control means 1B reverses the blood pump 14 so that the flow rate is about half of the flow rate by reverse filtration. Therefore, the dialysate is supplied from the dialysate supply passage 23 into the dialysate chamber 2C of the dialyzer 2, and the dialysate is press-fitted into the blood chamber 2C. The dialysate press-fitted into the blood chamber 2C is distributed into the passages 11 and 12 via the ports 2G and 2H by the reverse rotation of the blood pump 14. As a result, both the passages 11 and 12 are filled with the dialysate, and the dialysate is also introduced into the drip chamber 15 via the artery side passage 11. In the second embodiment, the saline bag 17 storing physiological saline is not used.
Although priming is performed in this way, it is assumed that bubbles remain in the first port 2G on the upper side of the dialyzer 2 in the final stage of priming (see FIG. 4A). The bubbles are removed using the adjusting means 5 as follows.
That is, first, the control means 1B once stops the reverse filtration, and in this state, the blood pump 14 is stopped and the second clamp means 13 ′ is opened. At the same time, the control means 1B opens the on-off valve V102 with the on-off valves V101, V103 closed, and rotates the air pump 8 in the normal direction. As a result, air is introduced into the drip chamber 15 via the atmospheric passage 6, so that the dialysate in the drip chamber 15 is pushed back into the blood chamber 2 </ b> C of the dialyzer 2 via the artery-side passage 11. . Along with this, the dialysate in the blood chamber 2 </ b> C is discharged to the vein side passage 12. Furthermore, since the air introduced into the drip chamber 15 is introduced into the upper part of the blood chamber 2C including the first port 2G via the artery-side passage 11, the newly introduced air and the first air are introduced first. The air bubbles in the first port 2G are integrated (see FIGS. 4A and 4B). That is, the dialysate in the upper part of the first port 2G and the blood chamber 2C is replaced with air. Even in the case of priming by reverse filtration, the introduction direction of the priming liquid into the blood chamber 2C is opposite to the introduction direction of air.
 この後、制御手段1Bは、第2クランプ手段13’を閉鎖してから再度透析液回路4により逆ろ過を行う(図4(c)参照)。つまり、再度、逆ろ過によるプライミングが行われる。これにより、透析液が血液室2Cに導入され、さらに第1ポート2Gから通路11内へ、さらにドリップチャンバ15内に透析液が導入される。これに伴い、上方側となる第1ポート2Gおよび血液室2Cの上部内の空気は、動脈側通路11を介してドリップチャンバ15の上部空間へと排出される。つまり、先に第1ポート2G内にあった気泡は、液面調整手段5により導入された空気と一体となってドリップチャンバ15へ確実に排出される。この後、制御手段1Bは、エアポンプ8を逆転させるので、ドリップチャンバ15内の空気が大気通路6を介して排出され、それに伴ってドリップチャンバ15内の透析液の液面が所要の高さまで上昇する(図4(c)参照)。
 このようにして、逆ろ過によって透析器2の透析液室2D,血液室2C内および血液回路3がプライミング液としての透析液で満たされて、プライミングが完了する。この逆ろ過によるプライミングの場合においても、液面調整手段5により透析器2の血液室2Cに空気を導入する前と後とで、2度にわたってプライミングを実施するようにしている。
 この逆ろ過によるプライミングの場合には、透析器2は透析治療時と同じ保持状態となっているので、この後、直ちに上述した透析治療に移行することができる。そして、この後、前述したようにして透析装置1による透析治療が実施される。
Thereafter, the control means 1B closes the second clamping means 13 ′ and then performs reverse filtration again with the dialysate circuit 4 (see FIG. 4C). That is, priming by reverse filtration is performed again. As a result, the dialysate is introduced into the blood chamber 2 </ b> C, and further dialysate is introduced from the first port 2 </ b> G into the passage 11 and into the drip chamber 15. Accordingly, the air in the upper portion of the first port 2G and the blood chamber 2C on the upper side is discharged to the upper space of the drip chamber 15 via the artery side passage 11. That is, the air bubbles previously in the first port 2G are reliably discharged into the drip chamber 15 together with the air introduced by the liquid level adjusting means 5. Thereafter, since the control means 1B reverses the air pump 8, the air in the drip chamber 15 is discharged through the atmospheric passage 6, and accordingly, the level of the dialysate in the drip chamber 15 rises to a required height. (See FIG. 4C).
In this way, the dialysate chamber 2D, blood chamber 2C and blood circuit 3 of the dialyzer 2 are filled with the dialysate as the priming solution by reverse filtration, and the priming is completed. Even in the case of priming by reverse filtration, the priming is performed twice before and after the air is introduced into the blood chamber 2C of the dialyzer 2 by the liquid level adjusting means 5.
In the case of the priming by reverse filtration, the dialyzer 2 is in the same holding state as that at the time of dialysis treatment, and thereafter, the dialysis treatment can be immediately performed. Thereafter, dialysis treatment by the dialysis apparatus 1 is performed as described above.
 以上に述べた第1実施例および第2実施例によれば、プライミングの際に透析器2の各ポート2H,2Gに小さな気泡が残留していたとしても、プライミングの最後段階において上方側に位置する各ポート2H,2Gを含めた血液室2C内に空気を敢えて導入することで、該導入された空気と各ポート2H、2G内の気泡とを一体となるようにしている。換言すると、上方側に位置する血液室2Cの上部内のプライミング液を敢えて所要量の空気に置換するようにしている。その状態において、各ポート2H,2Gおよび血液室2C内を再度プライミング液で満たして血液室2Cの外部へ空気を排出しているので、各ポート2H,2Gを含めた血液室2C内の気泡を確実に除去することができる。そのため、従来行っていたように現場の医療従事者が透析器2に衝撃を与えて内部の気泡を排出させる手間は必要ない。
 したがって、本実施例によれば、透析治療が行われる医療現場の医療従事者に作業負担を強いることなく、透析器2および血液回路3内から確実に気泡を除去することができる。
According to the first and second embodiments described above, even if small bubbles remain in the ports 2H and 2G of the dialyzer 2 at the time of priming, they are located on the upper side in the final stage of priming. By intentionally introducing air into the blood chamber 2C including the ports 2H and 2G, the introduced air and the bubbles in the ports 2H and 2G are integrated. In other words, the priming solution in the upper part of the blood chamber 2C located on the upper side is intentionally replaced with a required amount of air. In this state, the ports 2H and 2G and the blood chamber 2C are again filled with the priming solution and the air is discharged to the outside of the blood chamber 2C, so that the air bubbles in the blood chamber 2C including the ports 2H and 2G are removed. It can be removed reliably. Therefore, it is not necessary for the medical staff in the field to give a shock to the dialyzer 2 and discharge the internal bubbles as is conventionally done.
Therefore, according to the present embodiment, it is possible to reliably remove air bubbles from the dialyzer 2 and the blood circuit 3 without imposing a work burden on the medical staff at the medical site where dialysis treatment is performed.
 なお、上記第2の実施例では、第2のプライミング方式として逆ろ過によるプライミングを行っているが、異なる方式によって逆ろ過を行うようにしても良い。すなわち、例えば特開2003-180823号公報のように、透析液回収回路に設けた除水ポンプを逆回転させて逆ろ過する方式によりプライミングを行う場合にも本発明を適用することで気泡の除去を行うことできる。また、その他の方式によるプライミングであっても本発明による気泡の除去を行うことができる。
 また、上述した実施例においては、気体導入手段として上記液面調整手段5を利用しているが、それに代えて次のような構成を採用しても良い。つまり、図5に示すように、動脈側となるドリップチャンバ15と透析器2との間となる動脈側通路11に一方の気体導入手段51を設けるとともに、静脈側となるドリップチャンバ15’と透析器2との間となる静脈側通路12に他方の気体導入手段52とを設ければよい。ここで、気体導入手段51は、大気開放通路53とそれに設けた開閉弁V105、エアポンプ55および無菌フィルタ56から構成される。また、他方の気体導入手段52も気体導入手段51と同様に構成されるので、気体導入手段51と対応する各構成部材には、それぞれ’を付して示している。
 このような構成において、プライミングの最終段階において、前述した実施例のように、各気体導入手段51、52により、長手方向が鉛直方向となるように保持された透析器2の上方となっている各ポート2G又は、2Hを含めた血液室2C内に空気を導入してプライミング液を置換する。その後に、再度透析器2の各ポート2G又は、2Hを含めた血液室2C内をプライミング液で満たすことにより血液室2C内の気泡を確実に除去することができる。
In the second embodiment, priming by reverse filtration is performed as the second priming method. However, reverse filtration may be performed by a different method. That is, for example, as described in Japanese Patent Application Laid-Open No. 2003-180823, the present invention can be applied to remove bubbles by reversely rotating a dewatering pump provided in a dialysate recovery circuit and performing reverse filtration. Can be done. Further, the bubble removal according to the present invention can be performed even by priming by other methods.
In the embodiment described above, the liquid level adjusting means 5 is used as the gas introducing means, but the following configuration may be employed instead. That is, as shown in FIG. 5, one gas introduction means 51 is provided in the artery side passage 11 between the drip chamber 15 on the artery side and the dialyzer 2, and the drip chamber 15 ′ on the vein side is dialyzed. What is necessary is just to provide the other gas introduction means 52 in the vein side channel | path 12 between the vessels. Here, the gas introducing means 51 includes an atmosphere opening passage 53, an opening / closing valve V 105 provided in the atmosphere opening passage 53, an air pump 55, and a sterile filter 56. Further, since the other gas introducing means 52 is also configured in the same manner as the gas introducing means 51, each constituent member corresponding to the gas introducing means 51 is indicated by “′”.
In such a configuration, in the final stage of priming, as in the above-described embodiment, the gas introduction means 51 and 52 are above the dialyzer 2 held so that the longitudinal direction is the vertical direction. Air is introduced into the blood chamber 2C including each port 2G or 2H to replace the priming solution. After that, by filling the blood chamber 2C including the ports 2G or 2H of the dialyzer 2 again with the priming liquid, the air bubbles in the blood chamber 2C can be reliably removed.
1‥透析装置            2‥透析器
2C‥血液室            2G‥第1ポート
2H‥第2ポート          3‥血液回路
4‥透析液回路
5‥液面調整手段(気体導入手段)  11‥動脈側通路
12‥静脈側通路
14‥血液ポンプ(プライミング液供給手段)
17‥生食バッグ(プライミング液供給手段)
DESCRIPTION OF SYMBOLS 1 ... Dialyzer 2 ... Dialyser 2C ... Blood chamber 2G ... 1st port 2H ... 2nd port 3 ... Blood circuit 4 ... Dialysate circuit 5 ... Liquid level adjustment means (gas introduction means) 11 ... Arterial passage 12 ... Vein Side passage 14 Blood pump (priming fluid supply means)
17 ... Raw food bag (priming solution supply means)

Claims (6)

  1.  内部に血液室と透析液室とを有する透析器と、一端が採血口となり、他端が上記透析器の血液室の一端に接続される動脈側通路および一端が返血口となり、他端が上記血液室の他端に接続される静脈側通路とを有する血液回路と、上記透析器における透析液室の入口に接続される透析液供給通路および上記透析室の出口に接続される透析液回収通路とを有する透析液回路と、上記透析器の血液室および上記血液回路にプライミング液を供給するプライミング液供給手段とを備える透析装置において、
     上記動脈側通路又は静脈側通路に設けられた気体導入口から血液回路内に気体を導入する気体導入手段を設け、
     上記プライミング液で満たした上記透析器の血液室および上記血液回路に、上記気体導入口から気体を導入して、上記透析器における血液室の一方の端部とその隣接領域のプライミング液を気体で置換してから該血液室を再びプライミング液で満たすことにより、上記血液回路と上記透析器の血液室から気泡を除去することを特徴とする透析装置。
    A dialyzer having a blood chamber and a dialysate chamber inside, one end is a blood collection port, the other end is an arterial passage connected to one end of the blood chamber of the dialyzer and one end is a blood return port, and the other end is A blood circuit having a vein-side passage connected to the other end of the blood chamber, a dialysate supply passage connected to the inlet of the dialysate chamber in the dialyzer, and a dialysate recovery connected to the outlet of the dialyzer In a dialysis machine comprising a dialysate circuit having a passage, and a priming fluid supply means for supplying a priming fluid to the blood chamber of the dialyzer and the blood circuit,
    Providing gas introduction means for introducing gas into the blood circuit from the gas introduction port provided in the artery side passage or vein side passage;
    Gas is introduced from the gas inlet into the blood chamber of the dialyzer and the blood circuit filled with the priming solution, and the priming solution at one end of the blood chamber and the adjacent region in the dialyzer is gasified. A dialysis apparatus characterized by removing air bubbles from the blood circuit and the blood chamber of the dialyzer by refilling the blood chamber with a priming solution after replacement.
  2.  上記動脈通路および静脈通路には、それぞれ内部の液体の液面高さを調整可能なドリップチャンバが設けられており、上記気体導入口は、動脈側通路のドリップチャンバ又は静脈側通路のドリップチャンバに設けられることを特徴とする請求項1に記載の透析装置。 Each of the arterial passage and the venous passage is provided with a drip chamber capable of adjusting the liquid level of the liquid inside, and the gas introduction port is provided in the drip chamber of the arterial passage or the drip chamber of the venous passage. The dialysis apparatus according to claim 1, wherein the dialysis apparatus is provided.
  3.  上記透析器は長手方向が鉛直方向となるように保持されており、上記気体導入手段により、透析器の血液室の上方となる端部およびその隣接領域に気体を導入してプライミング液を気体に置換することを特徴とする請求項1又は請求項2に記載の透析装置。 The dialyzer is held so that its longitudinal direction is vertical, and the gas introduction means introduces gas into the upper end of the blood chamber of the dialyzer and its adjacent region to convert the priming solution into gas. The dialysis apparatus according to claim 1 or 2, wherein the dialysis apparatus is replaced.
  4.  内部に血液室と透析液室とを有する透析器と、一端が採血口となり、他端が上記透析器の血液室の一端に接続される動脈側通路および一端が返血口となり、他端が上記血液室の他端に接続される静脈側通路とを有する血液回路と、上記透析器における透析液室の入口に接続される透析液供給通路および上記透析室の出口に接続される透析液回収通路とを有する透析液回路と、上記透析器の血液室および上記血液回路にプライミング液を供給するプライミング液供給手段とを備え、上記透析器の血液室および血液回路にプライミング液を充満させるようにした透析装置のプライミング方法において、
     上記透析器の血液室および上記血液回路をプライミング液で満たす第1プライミング工程と、上記プライミング液で満たされた透析器の血液室の所定領域を気体で置換する気体導入工程と、上記気体導入工程において気体で置換された血液室の所定領域をプライミング液で再度満たす第2プライミング工程とを備えることを特徴とする透析装置のプライミング方法。
    A dialyzer having a blood chamber and a dialysate chamber inside, one end is a blood collection port, the other end is an arterial passage connected to one end of the blood chamber of the dialyzer and one end is a blood return port, and the other end is A blood circuit having a vein-side passage connected to the other end of the blood chamber, a dialysate supply passage connected to the inlet of the dialysate chamber in the dialyzer, and a dialysate recovery connected to the outlet of the dialyzer A dialysis fluid circuit having a passage, and a priming fluid supply means for supplying a priming fluid to the blood chamber of the dialyzer and the blood circuit, so that the blood chamber and blood circuit of the dialyzer are filled with the priming fluid. In the priming method for the dialyzer,
    A first priming step for filling the blood chamber of the dialyzer and the blood circuit with a priming solution; a gas introduction step for replacing a predetermined region of the blood chamber of the dialyzer filled with the priming solution with a gas; and the gas introduction step. And a second priming step for refilling a predetermined region of the blood chamber replaced with gas with a priming solution.
  5.  上記動脈通路および静脈通路には、それぞれ内部の液体の液面高さを調整可能なドリップチャンバが設けられており、上記気体導入工程においては、上記いずれかのドリップチャンバに設けられた気体導入口から透析器に気体を導入することを特徴とする請求項4に記載の透析装置のプライミング方法。 Each of the arterial passage and the venous passage is provided with a drip chamber capable of adjusting the liquid level height of the internal liquid. In the gas introduction step, a gas introduction port provided in any of the drip chambers The method for priming a dialysis device according to claim 4, wherein gas is introduced into the dialyzer.
  6.  上記透析器は長手方向が鉛直方向となるように保持されており、上記気体導入工程においては、上記透析器における上方側となる血液室の端部およびその隣接領域に気体を導入してプライミング液と置換することを特徴とする請求項4又は請求項5に記載の透析装置のブライミング方法。 The dialyzer is held so that its longitudinal direction is vertical, and in the gas introduction step, a gas is introduced into the end of the blood chamber on the upper side of the dialyzer and its adjacent region, and a priming solution is obtained. The dialysis device brimming method according to claim 4 or 5, wherein
PCT/JP2012/060820 2011-05-02 2012-04-23 Dialysis device and method for priming dialysis device WO2012150679A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011-102905 2011-05-02
JP2011102905A JP2012231985A (en) 2011-05-02 2011-05-02 Dialysis device and method for priming dialysis device

Publications (1)

Publication Number Publication Date
WO2012150679A1 true WO2012150679A1 (en) 2012-11-08

Family

ID=47107868

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/060820 WO2012150679A1 (en) 2011-05-02 2012-04-23 Dialysis device and method for priming dialysis device

Country Status (2)

Country Link
JP (1) JP2012231985A (en)
WO (1) WO2012150679A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022484B2 (en) 2013-02-06 2018-07-17 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6332605B2 (en) * 2014-02-27 2018-05-30 澁谷工業株式会社 Cleaning device and cleaning method for hemodialyzer
JP6496949B2 (en) * 2014-02-28 2019-04-10 株式会社ハイレックスコーポレーション Fluid processor attachment / detachment device

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113064A (en) * 1987-10-27 1989-05-01 Ube Ind Ltd Priming method of plasma exchanger
JPH0360671A (en) * 1989-07-28 1991-03-15 Yokogawa Electric Corp Automatic priming method for artificial dialytic device
JPH1133111A (en) * 1997-07-14 1999-02-09 Jms Co Ltd Easily primable blood processor and priming method therefor
JP2007190068A (en) * 2006-01-17 2007-08-02 Nipro Corp Blood purifying apparatus and automatic priming method of its blood circulation path
JP2009297339A (en) * 2008-06-16 2009-12-24 Nikkiso Co Ltd Blood purifying device and priming method thereof
JP2010125208A (en) * 2008-11-28 2010-06-10 Asahi Kasei Kuraray Medical Co Ltd Blood extracorporeal circulation apparatus and method of priming the same
JP2012034992A (en) * 2010-08-11 2012-02-23 Toray Medical Co Ltd Priming system for blood treater

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113064A (en) * 1987-10-27 1989-05-01 Ube Ind Ltd Priming method of plasma exchanger
JPH0360671A (en) * 1989-07-28 1991-03-15 Yokogawa Electric Corp Automatic priming method for artificial dialytic device
JPH1133111A (en) * 1997-07-14 1999-02-09 Jms Co Ltd Easily primable blood processor and priming method therefor
JP2007190068A (en) * 2006-01-17 2007-08-02 Nipro Corp Blood purifying apparatus and automatic priming method of its blood circulation path
JP2009297339A (en) * 2008-06-16 2009-12-24 Nikkiso Co Ltd Blood purifying device and priming method thereof
JP2010125208A (en) * 2008-11-28 2010-06-10 Asahi Kasei Kuraray Medical Co Ltd Blood extracorporeal circulation apparatus and method of priming the same
JP2012034992A (en) * 2010-08-11 2012-02-23 Toray Medical Co Ltd Priming system for blood treater

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022484B2 (en) 2013-02-06 2018-07-17 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
US10835662B2 (en) 2013-02-06 2020-11-17 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems
US11344658B2 (en) 2013-02-06 2022-05-31 Nxstage Medical, Inc. Fluid circuit priming methods, devices, and systems

Also Published As

Publication number Publication date
JP2012231985A (en) 2012-11-29

Similar Documents

Publication Publication Date Title
JP5724485B2 (en) Hemodialysis machine
EP2586474B1 (en) Hemodialysis device
EP2883558B1 (en) Blood purification device and priming method therefor
EP2857052B1 (en) Hemodialysis device operation method and hemodialysis device
US11679190B2 (en) Blood treatment device priming devices, methods, and systems
US20120150141A1 (en) Dialysis machine, a manifold for the dialysis machine and process
WO2012153623A1 (en) Dialysis device
WO2012150679A1 (en) Dialysis device and method for priming dialysis device
JP2009165500A (en) Blood purifying device and priming method thereof
CN109069723B (en) Blood purification system and priming method thereof
JP5276909B2 (en) Blood purification equipment
JP6011701B2 (en) Dialysis machine
CN109475673B (en) Dialysis device
WO2019244942A1 (en) Blood purification device and method for estimating nutritional state of patient using blood purification device
JP2009297340A (en) Blood purifying device
WO2019244941A1 (en) Blood purification device, and plasma flow rate acquisition method using blood purification device
JP5822152B2 (en) Hemodialysis machine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12779308

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12779308

Country of ref document: EP

Kind code of ref document: A1